日本臨牀 64/増刊号3 ヘルペスウイルス学

出版社: 日本臨牀社
発行日: 2006-03-28
分野: 臨床医学:一般  >  雑誌
雑誌名:
特集: ヘルペスウイルス学―基礎・臨床研究の進歩―
電子書籍版: 2006-03-28 (初版第1刷)
書籍・雑誌
≪全国送料無料でお届け≫
品切れ

16,170 円(税込)

電子書籍
章別単位での購入はできません
ブラウザ、アプリ閲覧

16,170 円(税込)

目次

  • 日本臨牀 64/増刊号3 ヘルペスウイルス学

    ―目次―

    特集 ヘルペスウイルス学―基礎・臨床研究の進歩―

    I. 概論    
     1 ヘルペスウイルス研究の歴史
     2 ヘルペスウイルスの分類
     3 ヘルペスウイルスゲノムの分子進化
     4 ヘルペスウイルスの組織親和性
     5 自然界におけるヘルペスウイルスの分布状況
     6 ヘルペスウイルス感染症    
     7 その他のヘルペスウイルス感染病    

    II. αヘルペスウイルス―単純ヘルペスウイルス(HSV)と
        水痘・帯状疱疹ウイルス(VZV)―    
     1 αヘルペスウイルスの分子生物学    
     2 αヘルペスウイルスに対する宿主応答    
     3 αヘルペスウイルス感染症発症機構    
     4 αヘルペスウイルス感染症の疫学    
     5 αヘルペスウイルス感染症の診断    
     6 αヘルペスウイルス感染症    
     7 αヘルペスウイルス感染症の治療と予防    
     8 αヘルペスウイルスの医学的利用    

    III. βヘルペスウイルス―ヒトサイトメガロウイルス(HCMV)と
        ヒトヘルペスウイルス6,7(HHV-6,7)―    
     1 βヘルペスウイルスの分子生物学    
     2 βヘルペスウイルスに対する宿主応答    
     3 βヘルペスウイルス感染症発症機構    
     4 βヘルペスウイルス感染症の疫学    
     5 βヘルペスウイルス感染症の診断    
     6 βヘルペスウイルス感染症    
     7 βヘルペスウイルス感染症の治療と予防    
     8 βヘルペスウイルスの医学的利用    

    IV. γヘルペスウイルス―EBウイルス(EBV)と
        カポジ肉腫関連ヘルペスウイルス(KSHV)―    
     1 γヘルペスウイルスの分子生物学    
     2 γヘルペスウイルスに対する宿主応答    
     3 γヘルペスウイルス感染症発症機構    
     4 γヘルペスウイルス感染症の疫学    
     5 γヘルペスウイルス感染症の診断    
     6 γヘルペスウイルス感染症    
     7 γヘルペスウイルス感染症の治療    
     8 γヘルペスウイルスの医学的利用  

この書籍の参考文献

参考文献のリンクは、リンク先の都合等により正しく表示されない場合がありますので、あらかじめご了承下さい。

本参考文献は電子書籍掲載内容を元にしております。

I 概論

P.12 掲載の参考文献
1) Burnet FM (ed) : Principles of Animal Virology, Academic Press, New York, 1955.
2) Kaplan AS (ed) : The Herpesviruses, Academic Press, New York, London, 1973.
3) Waterson AP, Wilkinson L (ed) : An Introduction to the History of Virology, Cambridge University Press, London, New York, Melbourne, 1978.
4) Rapp F (ed) : Oncogenic Herpesviruses Volume I and II, CRC Press, Florida, 1980.
5) Whitley RJ, Gnann JW Jr (ed) : Acyclovir : The Landmark Papers, Science Press, London, 1993.
P.18 掲載の参考文献
1) Regenmortel MHV, et al : Classification and nomenclature of viruses. In : Virus Taxonomy : Seventh Report of the International Committee on Taxonomy of Viruses, Academic press, San Diego, 2000.
2) Fauquet CM, et al : Classhication and nomenclature of viruses. In : Virus Taxonomy : Eighth Report of the International Committee on Taxonomy of Virruses, Elsevier Academic press, Amsterdam, 2005.
3) Roizman B, et al : The Family Herpesviridae : A brief introduction. In : Field Virology, Vol 2 (ed by Knipe DM, et al), p 2381-2397, Lippincott Williams & Wilkins, Philadelphia, 2001.
P.23 掲載の参考文献
1) 梅根健一, 坂岡博 : ヘルペスウイルスの分子進化. 遺伝 52 : 66-73, 1998.
P.28 掲載の参考文献
6) Soderberg-Naucler C, et al : Reactivation of latent human cytomegalovinls by allogeneic stimulation of blood cells from healthy donors. Cell 91 : 119-126, 1997.
P.32 掲載の参考文献
1) http://www.ncbi.nlm.nih.gov/ICTVdb/Ictv/fs_herpe.htm
3) VanDevanter DR, et al : Detection and analysis of diverse herpesviral species by consensus primer PCR. J Clin Microbiol 34 : 1666-1671, 1996.
4) Ehlers B, et al : Detection of new DNA polymerase genes of known and potentially novel herpesviruses by PCR with degenerate and deoxyinosine-substituted primers. Virus Genes 18 : 211-220, 1999.
5) Andrewes C, et al : Viruses of Vertebrates, 4th ed, Bailliere Tindall, London, 1978.
7) Adams JR, Bonami JR (ed) : Atlas of Invertebrate Viruses, CRC Press, Boca Raton, 1991.
8) 曹纓, 長谷川政美 : 分子系統樹推定におけるモデルのミススペシフィケーション-脊椎動物の系統進化を例として-. 統計数理 50 : 69-85, 2002.
P.47 掲載の参考文献
1) Roizman B, Pellett PE : The family Herpesviridae : A brief introduction. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2381-2397, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Kieff E, Rickinson AB : Epstein-Barr virus and its replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2511-2573, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Yoshiyama H, et al : Epstein-Barr Virus infection to human gastric carcinoma cells : Implication of the existence of a new virus receptor different from CD21. J Virol 71 : 5688-5691, 1997.
P.54 掲載の参考文献
1) Thomas JA, et al : Epstein-Barr virus gene expression and epithelial cell diiiferentiation in oral hairly leukoplakia. Am J pathol 139 : 1369-1380, 1991.
3) Read SJ, et al : Laboratory diagnosis of common viral infections of the central nervous system by using a single multiplex PCR secreting assay. J Clin Microbiol 37 : 1352-1355, 1999.
5) 倉田毅ほか : ウイルス感染. 現代病理学大系 5 (炎症と感染), p235-255, 中山書店, 1995.
9) 柏瀬光寿ほか : サイトメガロウイルス網膜炎の病理組織学的検討. 日眼会誌 108 : 415-422, 2004.
P.58 掲載の参考文献
P.64 掲載の参考文献
4) 栄鶴義人 : 新規抗ヘルペスウイルス剤. ウイルス 55 : 95-104, 2005.
10) Asano Y, et al : Postexposure prophylaxis of varicella in family contact by oral acyclovir. Pediatrics 92 : 219-222, 1993.
11) Hasegawa T, et al : Analysis of herpes simplex virus isolated from the genital lesions since 1977 in Japan. J Med Virol 63 : 57-63, 2001.
P.68 掲載の参考文献
P.72 掲載の参考文献
2) Hunt JR : On herpetic inflammations of the geniculate ganglion, a new syndrome and its complication. J Nerv Ment Dis 34 : 73-96, 1907.
5) Strous M, Davis GL : Viral disease of the labyrinth ; I review of the literature and discuss of the role of cytomegalovirus in congenital deafness. Ann Otol 82 : 577-583, 1973.
6) Whiteley RJ, et al : Gancyclovir treatment of symptomatic congenital cytomegalovirus infection ; Results of phase II study. J Infect Dis 175 : 1080-1086, 1997.
8) Jeffrey TV : Herpes simplex virus and Meniere'sdisease. Laryngoscope 113 : 1431-1438, 2003.
12) Pahor AL : Herpes zoster of the larynx : How common? J Otolaryngol 93 : 93-98, 1972.
13) 古川仭ほか : 上咽頭癌発癌とEBウイルス-ウイルス複製遺伝子に対する血清学的研究から-. JOHNS 14 : 1625-1629, 1998.
P.76 掲載の参考文献
2) Rogers SY, et al : Visceral varicella zoster infection after bone marrow transplantation without skin involvement and the use of PCR for diagnosis. Bone Marrow Transplant 15 : 805-807, 1995.
4) Zaia J : Cytomegalovirus infection. In : Hematopoietic Cell Transplantation (ed by Thomas ED, et al) p560-583, BlackWell Science, Malden, 1999.
7) Tanaka Y, et al : Monitoring cytomegalovirus infection by antigenemia assay and two distinct plasma real-time PCR methods after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 30 : 315-319, 2002.
8) Leruez-Ville M, et al : Monitoring cytomegalovirus infection in adult and pediatric bone marrow transplantation recipients by a real-time PCR assay performed with blood plasma. J Clin Microbiol 41 : 2040-2046, 2003.
12) Boeckh M, et al : Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation : A randomized double-blind study. Blood 88 : 4063-4071, 1996.
P.79 掲載の参考文献
1) 熊本悦明ほか : 日本における性感染症サーベイランス-2002年度調査報告-. 日性感染症誌 15 : 17-45, 2004.
3) 広瀬崇興 : STDとしてのαヘルペスウイルス感染症, 男性. 日本臨牀 58 : 877-882, 2000.
5) Corey L, Wald A : Genital herpes. In : Sexually Transmitted Diseases, 3rd ed (ed by Holmes KK, et al), p 285-312, McGraw-Hill, New York, 1999.
6) 本田まり子, 新村眞人 : 性器ヘルペス. 性感染症STD (熊澤浄一, 田中正利編), p 169-185, 南山堂, 2004.
7) 日本性感染症学会 : 性器ヘルペス. 性感染症 診断・治療 ガイドライン 2004. 日性感染症誌 15 (Suppl 1) : 17-20, 2004.
P.84 掲載の参考文献
5) 西澤美香ほか : 女性性器ヘルペス初感染例における型特異的血清診断に関する研究. 日性感染症誌 16 (1) : 97-103, 2005.
6) Patel R, et al : Valaciclovir for the suppression of recurrent genital HSV infection : aplacebo controlled study of once daily therapy. Genitourin Med 73 : 105-109, 1997.
13) 川名尚ほか : 単純ヘルペスウイルス母子感染の機序に関する一考察. 第22回日本産婦人科感染症研究会 学術講演会記録集, p55-57, 2004.
P.89 掲載の参考文献
3) 塩田洋 : HSV-2角膜炎. JHIF WORKSHOP 眼ヘルペスウイルス感染症の課題と対策, p 63-65, スタンダード・マッキンタイヤ, 1998.
4) 中川尚 : 単純ヘルペスウイルス2型 (HSV-2) と眼感染症. あたらしい眼科 15 (8) : 1077-1081, 1998.
5) Shimomura Y, et al : Herpes simple virus latency in human cornea. Jpn J Ophthalmol 37 : 318-324, 1993.
8) 坂井潤一 : 急性網膜壊死 (1) : 定義と症状. 新図説臨床眼科講座 7, 感染症とぶどう膜炎 (望月學編), p104-105, メジカルビュー社, 1999.
10) 田中稔, 二宮久子 : サイトメガロウイルス網膜炎. 眼の感染・免疫疾患 (大野重昭, 大橋裕一編), p62-65, メジカルビュー社, 1997.
P.93 掲載の参考文献
11) Majno G, Joris I : Apoptosis, oncosis, and necrosis. An overview of cell death. Am J pathol 146 : 3-15, 1995.
15) Andreansky S, et al : Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors. Cancer Res 57 : 1502-1509, 1997.
P.98 掲載の参考文献
3) 横井清 : 多形紅斑とHSV. 日皮会誌 105 : 1661-1664, 1995.
5) 竹内常道ほか : サイトメガロウイルスによるGianotti-Crosti症候群の1例. 臨床皮膚科 48 : 1193-1195, 1994.
6) Yasumoto S, et al : Case report : Gianotti-Crosti syndrome associated with human herpesvirus-6 infection. J Dermatol 23 (7) : 499-501, 1996.
8) 社団法人日本皮膚科学会 : Drug-induced hypersensitivity syndrome (http://www.dermatol.or.jp).
P.105 掲載の参考文献
2) Behrens GM, et al : Immune reconstitution syndromes in human immuno-de丘ciency virus infection following effective antiretroviral therapy. Immunobiology 202 : 186-193, 2000.
3) Bernabeu-Wittel M, et al : Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease : prospective assessment in a cohort of solid organ transplant recipients. J Infect 51 : 188-194, 2005.
9) Sashihara J, et al : High incidence of human herpesvirus 6 infection with a high viral load in cord blood stem cell transplant recipients. Blood 100 : 2005-2011, 2002.
P.112 掲載の参考文献
8) Nasisse MP, et al : Effects of valacyclovir in cats infected with feline herpesvirus 1. Am J Vet Med 58 : 1141-1144, 1997.
9) Campadelli-Fiume G, et al : The novel receptors that mediate the entry of herpes simplex viruses and animal alphaherpesviruses into cells. Rev Med Virol 10 : 305-319, 2000.
P.117 掲載の参考文献
1) Minson AC, et al : Family Herpesviridae. In : Virus Taxonomy : Classification and Nomenclatire of Viruses. Seventh Report of the International Committee on Taxonomy of Viruses, p 203-225, Academic Press, New York, 2000.
2) Plumb JA : Epizootiology of channel catfish virus disease. Marine Fisheries Review 40 : 26-29, 1978.
3) Wolf K, Dalington RW : Channel cadish Virus : a new herpesvirus of ictalurid fish. J Virol 8 : 525-533, 1971.
4) Davison AJ : The genome of salmonid herpesvirus 1. J Virol 72 : 1974-1982, 1998.
7) Yoshimizu M, et al : Salmonid herpesvirus 2 ; Epizootiology and selological relationship. Vet Res 29 : 486-492, 1995.
8) Kimura T, Yoshimizu M : Salmon herpesvirus : OMV, Oncorhynchus masou virus. In : Viruses of Lower Vertebrates (ed by Ahne W, Kurstak E), p 171-183, Springer Verlag, New York, 1988.
9) 木村喬久ほか : 魚類病原ウイルスに対する (S) -DHPA [(S) -9- (2, 3-dihydrooxypropyl) adenine] のin vitroにおける抗ウイルス効果. 北大水産彙報 38 : 151-155, 1987.
13) Perelberg A, et al : Epidemiological description of a new viral disease afflicting cultured Cyprinus carpio in Israel. Israeli J Aquacul Bamidgeh 55 : 5-12, 2003.

II αヘルペスウイルス - 単純ヘルペスウイルス ( HSV ) と水痘・帯状疱疹ウイルス ( VZV ) -

P.125 掲載の参考文献
1) Nii S : Electron microscopic study on the development of herpesviruses. J Electron Microsc 41 : 414-423, 1992.
2) Nli S, et al : Replication of human herpesvirus 6 (HHV-6) : morphological aspects. Adv Exp Med Biol 278 : 19-28, 1990.
4) Nii S, Morgan CR : Electronrnicroscopy of herpes simplex Virus. II. Sequence of development. J Virol 2 : 517-536, 1968.
5) Yoshida M, et al : High voltage electron microscopy of whole cells infected With herpes simplex virus type 1. J Electron Microsc 35 : 47-59, 1986.
8) Smith JD, Harven E : Herpes simplex virus and human cytomegalovirus replication in WI-38 cells. J Virol 12 : 919-930, 1973.
P.132 掲載の参考文献
2) Roizman B, Knipe DM : Herpes simplex viruses and their replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2399-2459, Lippincott Williams & Wilkins, Philadelphia, 2001.
P.138 掲載の参考文献
5) Moffat JF, et al : Tropism of varicella-zoster virus for human CD4+ and CD8+ Tlymphocytes and epidermal cells in SCID-hu mice. J Virol 69 : 5236-5242, 1995.
8) Gomi Y, et al : Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76 : 11447-11459, 2002.
15) Li Q, Cohen JI : Identification of a cellular receptor for varicella-zoster virus infection and cell-to-cell spread of virus. 30th International Herpesvirus Workshop : abstract 2. 3, 2005.
P.143 掲載の参考文献
1) Whitley R : Herpes simplex viruses. In : Fields Virology, 4th ed (ed by Knipe DM, et al), p 2461-2509, Lippincott-Williams & Wilkins, Philadelphia, PA, 2001.
2) 木村宏 : αヘルペスウイルス感染症の予防・治療-ワクチン. 日本臨牀 58 : 928-932, 2000.
3) 川口寧 : 単純ヘルペスウイルスを用いた 'human therapy'. Mebio 21 (4) : 24-33, 2004.
5) Roizman B, et al : Herpes simplex viruses and their replication. In : Fields Virology, 4th ed (ed by Knipe DM, et al), p 2399-2459, Lippincott-Williams & Wilkins, Philadelphia, PA, 2001.
6) 川口寧 : αヘルペスウイルス遺伝子関連事項-遺伝子発現制御機構. 日本臨牀 58 : 779-786, 2000.
7) Sandri-Goldin RM : Viral regulation of mRNA export. J Virol 78 : 4389-4396, 2004.
14) 川口寧, 田中道子 : BACシステム : 大腸菌の遺伝学とウイルス学が融合した新しいヘルペスウイルス遺伝子の改変法. ウイルス 54 : 255-264, 2004.
P.148 掲載の参考文献
1) Roizman B, et al : Herpes simplex viruses and their replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley P), p 2399-2460, Lippincott Williams and Wilkins, Philadelphia, 2001.
9) Miranda-Saksena M, et al : Anterograde transport of herpes simplex virus type 1 in cultured, dissociated human and rat dorsal root gangUon neurons. J Virol 74 : 1827-1839, 2000.
13) Ch'ng TH, Enquist LW : Efficient axonal localization of alphaherpesvirus structural proteins in cultured sympathetic neurons requires viral glycoprotein E. J Virol 79 : 8835-8846, 2005.
P.153 掲載の参考文献
12) 小山弘 : 喉頭筋延髄中枢に関する研究. 日気食会報 2 : 31-34, 1951.
P.157 掲載の参考文献
2) 川口寧 : αヘルペスウイルス遺伝子関連事項-遺伝子発現制御機構. 日本臨牀 58 : 779-786, 2000.
3) Kawaguchi Y, et al : Herpes simplex virus type 1α regulatory protein ICPO functionally interacts with acellular transcription factor BMAL1. Proc Natl Acad Sci USA 98 : 1877-1882, 2001.
4) Kawaguchi Y, et al : Interaction of herpes simplex virus 1α regulatory protein ICPO with elogation factor 1δ : ICPO affects translational machinery. J Virol 71 : 1019-1024, 1997.
7) Kawaguchi Y, et al : Herpes simplex virus-1α regulatory protein ICPO interacts with and stabilizes cell cycle regulator cyclin D3. J Virol 71 : 7328-7336, 1997.
P.162 掲載の参考文献
2) Marsters SA, et al : Herpes virus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-κB and AP-1. J Biol Chem 272 : 14029-14032, 1997.
4) Jordan R, et al : Characterization of a nerve growth factor-inducible cellular activity that enhances herpes simplex virus type 1 gene expression and replication of an ICPO null mutant in cells of neural lineage. J Virol 72 : 5373-5382, 1998.
9) Abendrot A, et al : Modulation of major histocompatibility class II protein expression by varicellazoster virus. J Virol 74 : 1900-1907, 2000.
P.166 掲載の参考文献
7) Flint SJ, et al : Assembly, exit and maturation. In : Principles of Virology, 2nd ed : Molecular Biology, Pathogenesis, and Control of Animal Viruses, p 450-491, American Society for Microbiology, Washington DC, 2004.
12) Yamauchi Y, et al : Herpes simplex virus type 2 UL14 gene product has heat shock protein (HSP) -like functions. J Cell Sci 115 : 2517-2527, 2002.
P.170 掲載の参考文献
1) Kerr JFR, Harmon BV : Definition and incidence of apoptosis : an historical perspective. In : Apoptosis II ; The Molecular Basis of Cell Death (ed by Tomei LD, Cope FO), p 5-29, Cold Spring Harbor Laboratory, New York, 1994.
9) 入江宏, 會田浄 : 単純ヘルペスウイルス感染とアポトーシス. 日本臨牀 58 : 794-800, 2000.
11) Clem RJ, Miller LK : Apoptosis reduces both the in vitro replication and the in vivo infectivity of baculovirus. J Virol 67 : 3730-3738, 1993.
12) Koyama AH, Miwa Y : Suppression of apoptotic DNA fragmentation in herpes simplex Virus type 1-infected cells. J Virol 71 : 2567-2571, 1997.
P.177 掲載の参考文献
2) Lekstrom-Himes JA, et al : Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice. J Virol 74 : 6680-6683, 2000.
4) 藤井暢弘 (編) : 特集 ウイルスの感染防御突破戦略. 蛋白質核酸酵素 49 : 501-533, 2004.
5) 竹田潔 (企画) : 特集 自然免疫システムの解明. 実験医学 23 : 1502-1542, 2005.
11) Mulvey M, et al : Regulation of eIF2α phosphorylation by dfferent functions that act during discrete phases in the herpes simplex virus type 1 life cycle. J Virol 77 : 10917-10928, 2003.
12) Everett RD, et al : Formation of nuclear foci of the herpes simplex virus type 1 regulatory protein ICP4 at early times of infection : localization, dynamics, recruitment of ICP27, and evidence for the de novo induction of NDIO-like complexes. J Virol 78 : 1903-1917, 2004.
P.182 掲載の参考文献
2) Bukowski JF, et al : Human γδT cell recognize alkylamines derived from microbes, edible plants, and tea : implications for innate immunity. Immunity 11 : 57-65, 1999.
3) Itohara S, et al : T cell receptor delta gene mutant mice : independent generation of alpha beta T cells and programmed rearrangements of gamma delta TCR genes. Cell 72 : 337-348, 1993.
5) Manickan E : Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes. J Immunol 155 : 259-265, 1995.
7) Nishimura H, et al : Intraepithelial γδT cells may bridge a gap between innate immunity and acquired immunity to herpes simplex virus type 2. J Virol 78 : 4927-4930, 2004.
P.187 掲載の参考文献
2) Grose C : Variation on a theme by Fenner : the pathogenesis of chickenpox. Pediatrics 68 : 735-737, 1981.
5) Ku CC, et al : Varicella-zoster virus transfer to skin by T cells and modulation of Viral replication by epidermal cell interferon-α. J Exp Med 200 : 917-925, 2004.
6) 占部和敬ほか : NK細胞活性の低下を認めた水痘の1例. 皮膚科の臨床 33 : 1851-1855, 1991.
8) 安元慎一郎 : 単純ヘルペスウイルスに対する表皮を介した免疫応答とその抑制. 医学のあゆみ 155 : 661, 1990.
10) Moffat JF, et al : Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse. J Virol 72 : 965-974, 1998.
P.191 掲載の参考文献
3) Goodman JL, Engel Jp : Altered pathogenesis in herpes simplex virus type 1 infection due to a syncytial mutation mapping to the carboxy terminus of glycoprotein B. J Virol 65 : 1770-1778, 1991.
4) Aubert M, et al : Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J Virol 73 : 10359-10370, 1999.
8) Dingwell KS, et al : Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol 69 : 7087-7098, 1995.
11) Yuhasz SA, Stevens JG : Glycoprotein B is a spechic determinant of herpes simplex virus type 1 neuroinvasiveness. J Virol 67 : 5948-5954, 1993.
13) Gerlmde R, et al : Transmission of pseudorabies virus from immune-masked blood monocytes to endothelial ceUs. J Gen Virol 84 : 629-637, 2003.
15) Roizman B, Knipe DM : Herpes simplex viruses and their replication. In : Fields Virology, 4th ed, Vol 2 (ed by Knipe DM, Howley PM), p 2399-2459, Lippincott Williams & Wilkins, Philadelphia, 2001.
P.196 掲載の参考文献
1) Whitley RJ, Hilliard JK : Cercopithecine herpesvirus (B virus). In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2835-2848, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Roizman B, Knipe DM : Herpes simplex viruses and their replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2399-2459, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Sawtell NM : Comprehensive quantification of herPes simplex virus 1 atency at the single-cell level. J Virol 71 : 5423-5431, 1997.
P.201 掲載の参考文献
1) 森勇, 西山幸廣 : ウイルスと感染のメカニズム-単純ヘルペスウイルス. 微生物感染学-新しい感染の科学- (光山正雄編), 南山堂, 2005.
12) Itzhaki R : Herpes simplex virus type 1, apolipoprotien E and Alzheimer'sdisease. Herpes 11 : 77A-82A, 2004.
P.208 掲載の参考文献
1) 川名尚, 橋戸円 : 微量中和法による型別抗単純ヘルペスウイルス抗体測定法の評価. 臨床とウイルス 19 : 347-351, 1991.
4) Ashley RL, et al : Comparison of western blot (immunoblot) and glycoprotein G-spechic immunodot enzyme assay for detecting antibodies to herpes simplex virus types l and 2 in human sera. J Clin Microbiol 26 : 662-667, 1988.
5) Schmid DS, et al : Limits in reliability of glycoprotein G-based type-specific serologic assays for herpes simplex virus types l and 2. J Clin Microbiol 37 : 376-379, 1999.
8) 薮田ゆみほか : 我が国におけるHSV型別抗体保有率の検討. 臨床とウイルス 27 : 182-186, 1999.
10) 鳥羽和憲 : 感染症の疫学-血清疫学の面から. ヘルペスウイルス感染症 (森良一, 川名尚編), p161-172, メディカルトリビューン, 1986.
12) 土屋英俊ほか : 看護学生における単純ヘルペスウイルスおよびサイトメガロウイルスに対する抗体保有率の低下とこれに関連する成育環境要因の検討. 小児感染免疫 9 : 95-102, 1997.
13) 伊香加納子ほか : 妊婦のヘルペス科ウイルス抗体保有率に関する検討. 日産婦埼玉地方部会誌 33 : 51-54, 2003.
14) 干場勉ほか : 過去10年間の当院におけるTORCH感染症. 日本産婦人科感染症研究会学術講演会記録集 19 : 30-33, 2002.
15) 橋戸円, 岡部信彦 : 発生動向調査からみた性感染症の最近の動向. 日性感染症誌 15 (Suppl) : 60-68, 2004.
P.213 掲載の参考文献
1) 梅根健一 : 分子疫学の理論と方法論の進歩. 日本臨牀 50 (特別号 : 感染症) : 119-124, 1992.
4) 梅根健一, 吉田正己 : ヘルペスウイルスの分子疫学. ウイルス 48 : 163-171, 1998.
5) 梅根健一 : 分子疫学の理論と方法. 日本臨牀 61 (増刊 : 新世紀の感染症学 (下)) : 435-440, 2003.
P.220 掲載の参考文献
1) 岡部信彦, 橋戸円 : 性感染症 (STD) 発生動向調査から見たわが国のSTDの動向-2004年. 厚生労働科学研究「性感染症の効果的な蔓延防止に関する研究班」 (主任研究者小野寺昭一) 研究報告書, 2005.
2) 熊本悦明ほか : 日本における性感染症 (STD) 流行の実態調査-2000年度のSTD・センチネル・サーベイランス報告-. 日性感染症誌 12 : 32-67, 2001.
3) 大阪府環境保健部・大阪府医師会 : 大阪府における性感染症動態調査概要, 平成7年度.
4) 永井宏ほか : 皮膚科における外陰ヘルペスの現況と多因子解析. 日性感染症誌 9 : 78-81, 1998.
5) 川名尚 : 性器ヘルペスの治療 日本化学療法学会誌 49 : 590-599, 2001.
6) 新村眞人 : アトラス「単純ヘルペス」, 臨床医薬研究協会, 2002.
8) Nahmias AJ, et al : Clinical aspects of infection with herpes simplex viruses land 2. In : The Human Herpesvirus (ed by Nahmias AI, et al), p 3-9, Elsevir, 1980.
11) Lee FK, et al : Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol 22 : 641-644, 1985.
13) 川名尚ほか : 1977年の妊婦における単純ヘルペスウイルス2型抗体保有率. 日性感染症誌 10 : 43, 1999.
14) 橋戸円ほか : わが国における単純ヘルペスウイルス2型特異抗体の保有状況. 医学のあゆみ 152 : 669-670, 1990.
15) 熊本悦明 : この性感染症流行の現状を直視して欲しい. 日性感染症誌 13 : 14-20, 2002.
16) 薮田ゆみほか : 我が国におけるHSV型別抗体保有率の検討. 臨床とウイルス 27 : 182-186, 1999.
P.225 掲載の参考文献
1) 木村三生夫 : 感染症発生動向調査2004概況. 臨床とウイルス 33 : 46-70, 2005.
2) 国立感染症研究所感染症情報センターホームページ (http://idsc.nih.go.jp/index-j.html).
P.229 掲載の参考文献
1) 森島恒雄 : 単純ヘルペス感染症の臨床. 周産期医学 13 : 1349-1353, 1983.
2) Kawada J, et al : Comparison of real-time and nested PCR assays for detection of herpes simplex virus DNA. Microbiol Immunol 48 : 411-415, 2004.
3) 安藤嘉浩ほか : PCR法による単純ヘルペス脳炎の早期診断. 小児感染免疫 4 : 19-22, 1992.
5) 木村宏ほか : 新生児ヘルペスにおけるウイルスゲノムの検出-PCR法による検討-. 臨床とウイルス 19 : 157-160, 1991.
6) 安藤嘉浩ほか : Polymerase chain reaction法による単純ヘルペス脳炎の早期診断. 日児誌 95 : 2381-2385, 1991.
P.232 掲載の参考文献
2) Gomi Y, et al : Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76 : 11447-11459, 2002.
4) Ozaki T, et al : The age distribution of neutralizing antibodies against varicella-zoster virus in healthy individuals. Biken J 23 : 9-14, 1980.
12) De Jong MD, et al : Quantitation of varicella-zoster virus DNA in whole blood, plasma, and serum by PCR and electrochemiluminescence. J Clin Microbiol 38 : 2568-2573, 2000.
P.238 掲載の参考文献
1) Specter S, et al : Diagnosis of virus infection. In : Clinical Virology, 2nd ed, p 243-272, ASM Press, Washington, DC, 2002.
2) 国立感染症研究所, 地方衛生研究所全国協議会 : 病原体検出マニュアル, 2003.
3) 橋戸円ほか : 一般成人における抗単純ヘルペスウイルスIgG, IgA, IgM抗体のELISA法による検討. 臨床とウイルス 17 : 391-396, 1989.
5) 日本神経感染症学会 : ヘルペス脳炎のガイドライン. Neuroinfection 10 : 78-87, 2005.
6) 川名尚, 相馬春江 : 単純ヘルペスウイルス型特異抗体測定ELISAキット「Gull」と「MRL」の比較検討. 臨床とウイルス 30 : 50-56, 2002.
7) Baba K, et al : Asimplified immunofluorescence technique for antibody to varicella-zoster membrane antigen (FAMA). Biken J 27 : 23-29, 1984.
8) Inoue S, et al : Changes in antibody avidity after virus infections : Detection by an immunosorbent assay in which a mild protein-denaturing agent is employed. J Clin Microbiol 20 : 525-529, 1984.
P.242 掲載の参考文献
1) 塩田洋 : HSV-2角膜炎. JHIF WORKSHOP 眼ヘルペスウイルス感染症の課題と対策, p 63-65, スタンダード・マッキンタイヤ, 1998.
2) 中川尚 : 単純ヘルペスウイルス2型 (HSV-2) と眼感染症. あたらしい眼科 15 (8) : 1077-1081, 1998.
4) 中川尚, 秦野寛 : 結膜炎. 眼感染症クリニック (臼井正彦ほか編), p15-33, 医学書院, 2000.
P.250 掲載の参考文献
1) 浦山晃ほか : 網膜動脈周囲炎と網膜剥離を伴う特異な片眼性急性ブドウ膜炎について. 臨床眼科 25 : 607-619, 1971.
5) 渡辺穣爾ほか : 網膜下液から単純ヘルペスウイルス1型を分離培養しえた急性網膜壊死の1例. 日眼会誌 93 : 65-71, 1989.
7) Lewis ML, et al : Herpes simplex virus type 1. A cause of the acute retinal necrosis syndrome. Ophthalmology 96 : 875-878, 1989.
12) Boer JH, et al : Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis. Am J Ophthalmol 121 : 650-658, 1996.
14) 西脇弘一ほか : Polymerase chain reaction法により単純ヘルペス1型DNAを検出した桐沢型ぶどう膜炎3症例. 臨床眼科 47 : 205-209, 1993.
16) 薄井紀夫ほか : ヘルペス性ぶどう膜炎における単純ヘルペスウイルスの型別. 日眼会誌 104 : 476-482, 2000.
26) 月本伸子ほか : 硝子体抽出液に対し, 病理学的ならびに血清学的検索を行った桐沢型ぶどう膜炎の1例. 臨床眼科 37 : 1055-1061, 1983.
31) 飯塚裕子ほか : 桐沢型ぶどう膜炎における髄液所見. 日眼会誌 103 : 442-448, 1999.
32) Tang Y, et al : Molecular diagnosis of herpes simplex virus infections in the central nervous system. J Clin Microbiol 37 : 2127-2136, 1999.
36) Blum MR, et al : Overview of acyclovir pharrnacokinetic disposition in adults and children. Acyclovir Symposium. Am J Med 73 : 186-192, 1982.
38) 坂井潤一ほか : 桐沢・浦山型ぶどう膜炎 (急性網膜壊死) の抗ウイルス療法と予後. 臨床眼科 85 : 876-881, 1991.
40) 佐藤雅美ほか : 桐沢型ぶどう膜炎患者の帯状疱疹ウイルスthymidine kinaseと各種サイトカインの眼内発現の検討. 日眼会誌 104 : 354-362, 2000.
41) 関文治ほか : 桐沢・浦山型ぶどう膜炎の手術療法. 臨床眼科 86 : 1912-1916, 1992.
P.255 掲載の参考文献
1) 川名尚 : 女性性器ヘルペス. ヘルペスウイルス感染症 (新村眞人, 山西弘一編), p169-175, 中外医学社, 1996.
2) Manavi K, et al : Herpes simplex virus type 1 remains the principal cause of initial anogenital herpes in Edinburgh, Scotland. Sex Transm Dis 31 : 322-324, 2005.
3) 川名尚, 相馬春江 : 単純ヘルペスウイルス型特異抗体測定 ELISAキット「Gull」と「MRL」の比較検討. 臨床とウイルス 30 : 50-56, 2002.
4) 菅生元康ほか : 塩酸バラシクロビル錠の性器ヘルペスに対する臨床効果 ; 一般臨床試験. 臨床医薬 18 : 1177-1192, 2002.
5) 森島恒雄ほか : 新生児ヘルペス全国調査. 日児誌 93 : 1990-1995, 1989.
P.259 掲載の参考文献
1) Arvin AM : Varicella-zoster virus. In : Fields Virology, 4th ed (ed by Knipe DM, et al), p 2731-2767, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) 庵原俊昭 : 免疫不全児と帯状疱疹. 第8回ヘルペス感染症フォーラム (ヘルペス感染症研究会編), p78-80, マッキャン・ヘルスケア, 2002.
3) Ihara T, et al : Human polymorphonuclear leukocyte-mediated cytotoxicity against varicella-zoster virus-infected fibroblasts. J Virol 51 : 110-116, 1984.
4) AAP (ed) : Varicella-zoster infections. In : Red Book, 26th ed, p 672-686, AAP, Elk Grove Village, 2003.
5) 庵原俊昭 : 水痘および帯状疱疹の治療. 化学療法の領域 15 : 1267-1272, 1999.
7) 中野貴司 : 水痘感染における免疫機能低下の評価と対策. 小児内科 37 : 786-789, 2005.
8) McCarter-Spaulding DE : Varicella infection in pregnancy. J Obstet Gynecol Neonatal Nurs 30 : 667-673, 2001.
9) CDC : Pregnancy outcomes following systemic prenatal acyclovir exposure-June 1, 1984-June 30, 1993. MMWR Morb Mortal Wkly Rep 42 (41) : 806-809, 1993.
10) 庵原俊昭 : 水痘帯状疱疹. 小児科 45 : 583-586, 2004.
11) 中野貴司 : 先天性水痘と周産期水痘. 水痘と治療 (神谷齊ほか編), p22-25, チャーチル・コミュニケーションズ・ジャパン, 1997.
12) 庵原俊昭 : 先天性ウイルス感染-水痘. 臨床と微生物 18 : 161-165, 1991.
P.263 掲載の参考文献
1) 吉田正己 : 単純ヘルペス, 水痘・帯状疱疹-周辺疾患を含めて-, p12-41, メディカルトリビューン, 1991.
3) Schifnemann S, et al : Subclinical reactivation of varicella-zoster virus in imunocompromised and immunocompetent individuals. Intervirology 41 : 98-102, 1998.
4) 田中信ほか : 再発性帯状疱疹. 臨床皮膚科 47 : 31-33, 1993.
6) 角田孝彦ほか : 水痘・帯状疱疹の水庖の中心臍窩について. 皮膚科の臨床 41 : 765-769, 1999.
9) Takayama M, et al : Application of long PCR method to identification of variations in nucleotide sequences among varicella-zoster virus isolates. J Clin Microbiol 34 : 2869-2874, 1996.
10) 吉田正己 : αヘルペスウィルス感染症の分子疫学. 日本臨牀 58 : 838-843, 2000.
13) 角田孝彦ほか : 帯状疱疹後にみられた葦麻疹の臨床的検討. 臨床皮膚科 54 : 953-955, 2000.
14) 吉田正己ほか : 免疫不全を伴う高齢者に発症した水痘. 皮膚科の臨床 29 : 945-949, 1987.
P.267 掲載の参考文献
7) 石原健司ほか : 単純ヘルペス脳炎における健忘の検討. 脳と神経 52 : 979-983, 2000.
9) 平野智哉ほか : 妊娠単純ヘルペス脳炎の1例. 日内会誌 94 : 747-749, 2005.
10) 日本神経感染症学会 : ヘルペス脳炎のガイドライン. Neuroinfection 10 : 78-87, 2005.
11) Tyler KL : Herpes simplex Virus tnfections of the central nervous system : encephalitis and meningitis, including Mollaret's. Herpes 11 (Suppl 2) : 57A-64A, 2004.
12) Asaoka K, et al : Non-herpetic acute limbic encephalitis. Intern Med 43 : 42-48, 2004.
P.271 掲載の参考文献
1) 森島恒雄ほか : 新生児ヘルペス全国調査. 日児誌 93 : 1990-1995, 1989.
3) ACOG practice bulletin. Management of herpes in pregnancy. Clinical management guidelines for obstetdcian-gynecologists. Int J Gynaecol Obstet 68 : 165-173, 2000.
9) Kimberlin D : Herpes simplex virus, meningitis and encephalitis in neonates. Herpes 11 (Suppl 2) : 65A-76A, 2004.
P.275 掲載の参考文献
1) 中嶋秀人 : 中枢神経系のヘルペス感染症. 化学療法の領域 20 : 1479-1484, 2004.
3) 石井慶蔵ほか : ウイルス関連神経感染症の疫学. 日本臨牀 55 : 839-848, 1997.
4) 庄司紘史ほか : 九州・沖縄地区の単純ヘルペスウイルス神経感染症. NEUROINFECTION 3 : 49-50, 1998.
6) Tyler KL : Herpes simplex virus infections of the central nervous system : encephalitis and meningitis, including Mollaret's. Herpes 11 (Suppl 2) : 57A-64A, 2004.
7) 庄司紘史 : 単純ヘルペスウイルス1型 (HSV1), 2型 (HSV2). 別冊日本臨牀神経症候群 1, p 418-422, 日本臨牀社, 1999.
9) Mollaret P : La m6ningite endothelio-leukocytaire multi-recurrence benigne : syndrome nouveau ou maladie nouvelle? Rev Neurol (Paris) 76 : 57-76, 1944.
11) Steel JG, et al : Isolation of herpes simplex virus type 1 in recurrent (Mollaret's) meningitis. Trans Am Neurol Assoc 106 : 37-42, 1981.
12) 橋口英志 : 再発性無菌性髄膜炎. 単純ヘルペスウイルス感染症の再発抑制 (JHIF Workshop Proceedings), p 42-44, マッキャン・ヘルスケア, 2002.
15) 林良一, 大原慎司 : Elsberg症候群. Annual Review神経 (柳澤信夫ほか編), p 126-132, 中外医学社, 2004.
P.279 掲載の参考文献
3) Funlta Y, et al : Detection of varicella-zoster virus DNA in human geniculate ganglia by polymerase chain reaction. J Infect Dis 166 : 1157-1159, 1992.
12) Honda N, et al : Pathology of facial nerve paralysis induced by herpes simplex virus type 1 infection. Ann Otol Rhinol Laryngol 111 : 616-622, 2002.
13) Stennert E : New concept in the treatment of Bell's palsy. In : Disorders of the Facial Nerve, p 313-317, Raven Press, New York, 1982.
14) Adour KK, et al : Bell's palsy treatment with acyclovir and prednisone compared with prednisone alone ; A double -blind, controlled tHal. Ann Otol Rhinol Laryngol 105 : 371-378, 1996.
P.284 掲載の参考文献
P.289 掲載の参考文献
4) Lobaro RD, Madrid JL : Clinical and physiopathological mechanisms of postherpetic neuralgia. Clin J Pain 2 : 253-257, 1987.
5) 新村眞人 : 帯状疱疹後神経痛. 日皮会誌 100 : 1352-1354, 1990.
6) Tsker RR, Dostrovsky FO : Deafferentation and central pain. In : Textbook of Pain, 2nd ed (ed by Wall PD, Melzack R), p 154-180, Churchill Livingstone, Edinburgh, 1989.
8) Esiri MM, Tomlinson AH : Herpes zoster, Demonstration of virus in trigeminal nerve and ganglion by immunofluorescence and electron microscopy. J Neurol Sci 15 : 35-48, 1972.
P.294 掲載の参考文献
3) Cohen JI, et al : Recommendations for prevention of and therapy for exposure to B virus (Cercophithecine herpesvirus 1). Clin Infect Dis 35 : 1191-1203, 2003.
8) Wood W, Shimada Fr : Isolation of strains of Virus B from tissue cultures of Cynomolgus and rheusus kidney. Can J Public Health 45 : 509-518, 1954.
10) Smith AL, et al : Molecular evidence for distinct genotypes of monkey B virus (Herpesvirus simiae) which are related to the macaque host species. J Virol 72 : 9224-9232, 1998.
13) Ohsawa K, et al : Sequence and genetic arrangement of the UL region of the monkey B virus (Cercopithecine herpesvirus 1) genome and comparison with the UL regions of other primate herpesviruses. Arch Virol 148 : 989-997, 2003.
P.301 掲載の参考文献
1) 日本神経感染症学会 : ヘルペス脳炎のガイドライン. Neuroinfection 10 : 78-87, 2005.
2) Skoldenberg B, et al : Acyclovir versus vidarabine in herpes simplex encephalitis : randomised multicentre study in consecutive Swedish patients. Lancet ii : 707-711, 1984.
7) Domingues RB, et al : Diagnosis of herpes simplex encephalitis by magnetic resonance imaging and polymerase chain reaction assay of cerebrospinal fluid. J Neurol Sci 157 : 148-153, 1998.
16) Rsler A, et al : Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J Neurol Sci 157 : 82-89, 1998.
17) 皆川洋子 : 単純ヘルペスウイルス (Herpes simplex Virus) -多彩なウイルス遺伝子の感染病理における役割の解明と宿主の関与-. ウイルス 52 : 109-115, 2002.
P.305 掲載の参考文献
1) 森島恒雄ほか : 新生児ヘルペス全国調査. 日児誌 93 : 1990-1995, 1989.
2) Whitley RJ : Herpes simplex virus. In : Fields Virology (ed by Knipe DM, Howley PM), p 2461-2510, Lippincot-Williams & Wilkins Publications, Philadelphia, 2001.
3) 木村宏ほか : 新生児ヘルペス全身型に伴う肝機能異常の早期診断における重要性について. 日児誌 95 : 955-959, 1991.
7) Elion GB, et al : The selectivity of action of an antiherpetic agent, 9- (2-hydroxy-methyl) guanine. Proc Natl Acad Sci USA 74 : 5716-5720, 1977.
10) American Academy of Pediatrics : Antiviral drugs for non-human immunodeficiency Virus infection. In : Red Book : 2003 Report of the Committee on Infectious Diseases, 26th ed (ed by Pickering LK), p 729 -732, American Academy of Pediatrics, Elk Grove Village, 2003.
P.309 掲載の参考文献
P.315 掲載の参考文献
1) 北野周作ほか : アシクロビル (ACV) とIDU眼軟膏との単純ヘルペス性角膜炎に対する治療効果の二重盲検法による比較検討. 眼科臨床医報 77 : 1273-1280, 1983.
2) Field AK, et al : (±)-(1α, 2β, 3α) -9- [2, 3-Bis (hydroxymethyl) -cyclobutyl] guanine [ (±) -BHCG or SQ 33054] : a potent and selective inhibitor of herpesviruses. Antiviral Res 13 : 41-52, 1990.
4) Yamanaka G, et al : Selective activity and cellular pharmacology of (1R-1α, 2β, 3α) -9- [2, 3-bis (hydroxymethyl) cyclobutyl] guanine in herpesvirus-infected cells. Mol Pharmacol 40 : 446-453, 1991.
6) 臼井正彦 : 水痘・帯状疱疹ウイルス (VZV) による急性網膜壊死 (ARN). JHIF WORKSHOP眼ヘルペスウイルス感染症の課題と対策 (ヘルペス感染症研究会編), p50-52, (株) スタンダード・マッキンタイヤ, 1998.
8) 中川尚 : 単純ヘルペスウイルス2型 (HSV-2) と眼感染症. あたらしい眼科 15 : 1077-1081, 1998.
9) 塩田洋 : HSV-2角膜炎. JHIF WORKSHOP眼ヘルペスウイルス感染症の課題と対策 (ヘルペス感染症研究会編), p63-65, (株) スタンダード・マッキンタイヤ, 1998.
P.319 掲載の参考文献
3) Sawtell NM : Comprehensive quantification of herpes simplex virhs latency at the single-cell level. J Virol 71 : 5423-5431, 1997.
4) Sawtell NM, et al : The latent herpes simplex virus type 1 genome copy number in individual neurons is virus strain specific and correlates with reactivation. J Virol 72 : 5343-5350, 1998.
5) Lekstrom-Himes JA, et al : The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus type 1 and 2 cause recurrent genital herpes outbreaks. J Virol 72 : 2760-2764, 1998.
6) Sexually transmitted diseases treatment guidelines 2002. Centers for Disease Control and Prevention. MMWR Recomm Rep 51 (RR-6) : 1-78, 2002.
10) 本田まりこ, 新村眞人 : 再発性単純ヘルペスに抗ウイルス薬による抑制療法は有効か? 日皮会誌 111 : 1795-1797, 2001.
14) Diaz-Mitoma F, et al : Oral famciclovir for the suppression of recurrent genital herpes : A randomized controlled trial. JAMA 280 : 887-892, 1998.
P.324 掲載の参考文献
2) 神谷齊 : 小児白血病のウイルス感染症と予防接種. 小児科MOOK, No 20 (赤羽太郎編), p153-169, 金原出版, 1981.
3) Takahashi M, et al : A live varicella vaccine. Adv Exp Med Biol 278 : 49-58, 1990.
5) Gomi Y, et al : Comparison of the complete DNA sequences of the Oka varicella vaccine and its parental virus. J Virol 76 : 11447-11459, 2002.
7) 神谷齊ほか : 白血病児の予防接種. 小児医学 21 (1) : 157-173, 1988.
9) 尾崎隆男 : 当院における水痘ワクチン10年の成果. 臨床とウイルス 27 (1) : 22-28, 1999.
11) Asano Y, et al : Experience and reason : twenty-year follow-up of protective immunity of the Oka strain live varicell vaccine. Pediatrics 94 (4 Pt 1) : 524-526, 1994.
12) 神谷齊ほか : 水痘ワクチン前方視的調査全国集計 (第11報). 厚生労働科学研究「安全なワクチン確保とその接種方法に関する総合研究報告書」, p108-109, 2005.
P.332 掲載の参考文献
6) Yamamura H, et al : Aberrant methylation and silencing of the calponin gene in human sarcoma cells. Anticancer Res 23 : 107-114, 2003.
8) Takahashi K, Nadal-Ginard B : Molecular cloning and sequence analysis of smooth muscle calponin. J Biol Chem 266 : 13284-13288, 1991.
10) EL-Mezgueldi M, Marston SB : The effects of smooth muscle calponin on the strong and weak myosin binding sites of F-actin. J Biol Chem 271 : 28161-28167, 1996.
13) Taniguchi S, et al : Structural fragility of blood vessels and peritoneum in calponin h1-deficient mice, resulting in an increase in hematogenous metastasis and peritoneal dissemination of malignant tumor cells. Cancer Res 61 : 7627-7634, 2001.
14) Yamamura H, et al : Identhication of the transcriptional regulatory sequences of human calponin promoter and their use in targeting a conditionally replicating herpes vector to malignant human soft tissue and bone tumors. Cancer Res 61 : 3969-3977, 2001.
15) DeLuca NA, et al : Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regtilatory protein ICP4. J Virol 56 : 558-570, 1985.
16) Yamamura H, Takahashi K : Targeted disruption of tumor vasculature with a multi-mutated, replication-competent type 1 herpes simplex virus (HSV-1) expressing RS1 gene under the control of smooth muscle-specific human calponin promoter. Mol Ther 7 : 293-294, 2003.
P.338 掲載の参考文献
1) DePace N : Sulla scomparsa di un enorme cancro vegetante del collo dell' utero senza cura chirurgia. Ginecologia 9 : 82-89, 1912.
2) Levaditi C, Nicolau S : Sur le culture du virus vaccinal dans les neoplasmes epithelieux. CR Soc Biol 86 : 928, 1922.
4) Southan CM, Moore AE : Clinical studies of viruses as antineoplastic agents, with particular reference to Egypt 101 virus. Cancer 5 : 1025-1034, 1952.
7) Phase I trial of NV1020 against liver metastasis. (http://clinicaltrials.gov)
8) Hu JC, et al : A phase I clinical trial with OncoVexGM-CSF. Proc Am Soc Clin Oncol 22 : 185, 2003.
9) Kimata H, et al : Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses. Hepatogastroenterology 50 (52) : 961-966, 2003.
14) Nakamura H, et al : Multimodality therapy widl a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil. Cancer Res 61 (14) : 5447-5452, 2001.
P.344 掲載の参考文献
1) Takahashi M, et al : Development of a live attenuated varicella vaccine. Biken J 18 : 25-33, 1975.
13) Heineman TC, et al : Immunization with recombinant varicella-zoster virus expressing herpes simplex virus type 2 glycoprotein D reduces the severity of genital herpes in guinea pigs. J Virol 69 : 8109-8113, 1995.
P.348 掲載の参考文献
1) Crumpacker C : Antiviral therapy. In : Fields Virology (ed by Knipe DM, Howley PM), p 393-403, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Freeman SM, et al : The 'bystander effect' : tumor regression when a fraction of the tumor mass is genetically modified. Cancer Res 53 : 5274-5283, 1993.
7) Vrionis FD, et al : The bystander effect exerted by tumor cells expressing the herpes simplex virus thymidine kinase (HSV-TK) gene is dependent on connexin expression and cell communication via gap junctions. Gene Ther 4 : 577-585, 1997.
11) Gagandeep S, et al : Prodrug-activated gene therapy : involvement of an immunological component in the 'bystander effect'. Cancer Gene Ther 3 : 83-88, 1996.
12) Ramesh R, et al : Expression of costimulatory molecules : B7 and ICAM up-regulation after treatment with a suicide gene. Cancer Gene Ther 3 : 373-384, 1996.
13) Ram Z, et al : Summary of results and conclusions of the gene therapy of malignant brain tumors : clinical study. J Neurosurg 82 : 343A, 1995.
20) Shalaby WSW, et al : Ganciclovir delivery systems for gene therapy of ovarian cancer. Society of Gynecologic Oncologists 31st Annual Meeting, San Diego, CA, February 6-9, 2000.
P.354 掲載の参考文献
3) Yazaki T, et al : Treatment of human malignant meningiomas by G207, a replication-competent multimutated herpes simplex virus 1. Cancer Res 55 : 4752-4756, 1995.
5) Miller CG, Fraser NW : Role of the immune response during neuro-attenuated herpes simplex virus-mediated tumor destruction in a murine intracranial melanoma model. Cancer Res 60 : 5714-5722, 2000.
11) Kimata H, et al : Effective treatment of disseminated peritoneal colon cancer with new replication-competent herpes simplex viruses. Hepatogastroenterology 50 : 961-966, 2003.
P.359 掲載の参考文献
P.365 掲載の参考文献
2) DeLuca NA, et al : Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4. J Virol 56 : 558-570, 1985.
4) Stevens JG : Human herpesviruses : a consideration of the latent state. Microbiol Rev 53 : 318-332, 1989.
P.370 掲載の参考文献
5) AIDSVAX fails to prove efficacious in large-scale trial. Expert Rev Anti Infect Ther 1 : 527, 2003.
6) Excler JL : AIDS vaccine development : perspectives, challenges & hopes. Indian J Med Res 121 : 568-581, 2005.
10) Samaniego LA, et al : Persistence and expression of the herpes simplex virus genome in the absence of immediate-early proteins. J Virol 72 : 3307-3320, 1998.

III βヘルペスウイルス - ヒトサイトメガロウイルス ( HCMV ) とヒトヘルペスウイルス6, 7 ( HHV - 6, 7 ) -

P.376 掲載の参考文献
1) Mocarshi ES, Courcelle CT : Cytomegaloviruses and their replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2629-2673, Lippincott Williams & Wilkins, Philadelphia, 2001.
3) Liu B, Stinshki MF : Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1 cis-acting elements. J Virol 66 : 4434-4444, 1992.
4) Krosky PM, et al : Resistance of human cytomegalovirus to benzimidazole ribonucleosides maps to two open reading frames : UL89 and UL56. J Virol 72 : 4721-4728, 1998.
6) Gibson W, et al : D, L-α-dMuoromethylornithine inhibits human cytomegalovirus replication. J Virol 50 : 145-154, 1984.
7) Prichard MN, et al : Identification of persistent RNA-DNA hybrid structures Within the origin of replication of human cytomegalovirus. J Virol 72 : 6997-7004, 1998.
8) Pellett PE, Dominguez G : Human herpesviruses 6A, 6B, and 7. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2769-2784, Lippincott Williams & Wilkins, Philadelphia, 2001.
P.380 掲載の参考文献
2) Cha TA, et al : Human cytomegalovirus clinical isolates carry at least 19 genes not found in laboratory strains. J Virol 70 : 78-83, 1996.
10) Chambers J, et al : DNA microarrays of the complex human cytomegalovirus genome : profiling kinetic class with drug sensitivity of viral gene expression. J Virol 73 : 5757-5766, 1999.
14) Meyer-Konig U, et al : Glycoprotein B genotype correlates with cell tropism in vivo of human cytomegalovirus infection. J Med Virol 55 : 75-81, 1998.
15) Arav-Boger R, et al : Polymorphisms of the cytomegalovirus (CMV) -encoded tumor necrosis factor-alpha and beta-chemokine receptors in congenital CMV disease. J Infect Dis 186 : 1057-1064, 2002.
P.392 掲載の参考文献
1) Ansari A, Emery VC : The U69 gene of human herpesvirus 6 encodes a protein kinase which can confer ganciclovir sensitivity to baculoviruses. J Virol 73 : 3284-3291, 1999.
5) Dominguez G, et al : Human herpesvirus 6B genome sequence : coding content and comparison with human herpesvirus 6A. J Virol 73 : 8040-8052, 1999.
11) Isegawa Y, et al : Comparison of the complete DNA sequences of human herpesvirus 6 variants A and B. J Virol 73 : 8053-8063, 1999.
12) Isegawa Y, et al : Human herpesvirus 6 open reading frame U12 encodes a functional beta-chemokine receptor. J Virol 72 : 6104-6112, 1998.
21) Nicholas J : Determination and analysis of the complete nucleotide sequence of human herpesvirus. J Virol 70 : 5975-5989, 1996.
23) Pellett PE, Dominguez G : Human herpesviruses 6A, 6B and 7 and their replication. In : Fields Virology, Vol 2, Chapter 80, 4th ed (ed by Knipe DM, Howley PM), p 2769-2784, Lippincott Williams & Wilkins, Philadelphia, 2001.
28) Stefan A, et al : The 85-kilodalton phosphoprotein (pp85) of human herpesvirus 7 is encoded by open reading frame U14 and localizes to a tegument substructure in virion particles. J Virol 71 : 5758-5763, 1997.
33) Tigue NJ, et al : Cloning, expression and characterization of the proteinase from human herpesvirus 6. J Virol 70 : 4136-4141, 1996.
35) Zou P, et al : Human herpesvirus 60pen reading frame U83 encodes a functional chemokine. J Virol 73 : 5926-5933, 1999.
P.399 掲載の参考文献
8) Chambers J, et al : DNA microarrays of the complex human cytomegalovirus genome : profiling kinetic class with drug sensitivity of viral gene expression. J Virol 73 (7) : 5757-5766, 1999.
P.403 掲載の参考文献
3) 干場勉 : 妊婦のサイトメガロウイルス抗体保有率の低下. 日本臨牀 56 : 193-196, 1998.
4) Jhonson RA, et al : Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway : inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J Virol 75 : 6022-6032, 2001.
5) Bolle LD, et al : Update on human herpesvirus 6 biology, clinical features, and therapy. Clin Microbiol Rev 18 : 217-245, 2005.
P.411 掲載の参考文献
1) Mocarski ES, Courcelle CT : Cytomegaloviruses and their replication. In : Fields Virology (ed by Knipe DM, et al), p 2629-2673, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Ho M : Cytomegalovirus : Biology and Infection, 2nd ed, Plenum, New York, 1991.
3) Pass RF : Cytomegalovirus. In : Fields Virology (ed by Knipe DM, et al), p 2675-2705, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Smith MG, Vellios F : Inclusion disease or generalized salivary gland virus infection. AMA Arch Pathol 50 : 862-884, 1950.
5) Rawlinson WD, et al : Analysis of the complete DNA sequence of murine cytomegalovirus. J Virol 70 : 8833-8849, 1996.
9) Borysiewicz LK, et al : Lysis of human cytomegalovirus infected fibroblasts by natural killer cells : demonstration of an interferon-independent component requiring expression of early viral proteins and characterization of effector cells. J Immunol 134 : 2695-2701, 1985.
11) Davignon JL, et al : Anti-human cytomegalovirus activity of cytokines produced by CD4 (+) T-cell clones specifically activated by IE1 peptides in vitro. J Virol 70 : 2162-2169, 1996.
12) Quinna GV, et al : Cytotoxic T cells in cytomegalovirus infection : HLA-restricted T-lymphocyte and non-T-lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus infection in bone-marrow-transplant recipients. N Engl J Med 307 : 7-13, 1982.
13) Riddel SR, Greenburg PD : Tcell therapy of human CMV and EBV infection in immunocompromised hosts. Rev Med Virol 7 : 181-192, 1997.
15) Snydman DR, et al : Use of cytomegalovirus immune globlin to prevent cytomegalovirus diseases in renal transplant recipients. N Engl J Med 317 : 1049-1054, 1987.
17) Campbell A : Murine cytomegalovirus. In : Persistent Viral Infections (ed by Ahmed R, Chen SY), p447-466, John Willy & Sons Ltd, Baffins lane, 1999.
18) Selgrade MK, Osborn JE : Role of macrophages in resistance to murine cytomegalovirus. Infect Immun 10 : 1383-1390, 1974.
21) Mogensen SC : Role of macrophages on natural resistance to virus infections. Microbiol Rev 43 : 1-26, 1979.
22) Hanson LK, et al : Replication of murine cytomegalovirus in ditiferentiated macrophages as a determinant of viral pathogenesis. J Virol 73 : 5970-5980, 1999.
24) Soderberg-Naucler C, et al : Reactivation of latent cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 : 119-126, 1997.
25) Bale JF, O'Neil ME : Detection of murine cytomegalovirus DNA in circulating leukocytes harvested during acute infection of mice. J Virol 63 : 2667-2673, 1989.
26) Collins TM, et al : Biphasic viremia and viral gene expression in leukocytes during acute cytomegalovirus infection of mice. J Virol 68 : 6305-6311, 1994.
27) Stoddart CA, et al : Peripheral blood mononuclear phagocytes mediate dissemination of murine cytomegalovirus. J Virol 68 : 6243 -6253, 1994.
28) Koffron AJ, et al : Cellular localization of latent murine cytomegalovirus. J Virol 72 : 95-103, 1998.
32) MacDonald MR, et al : Spliced mRNA encoding the murine cytomegalovirus chemokine homolog predicts a beta chemoldne of novel structure. J Virol 73 : 3682-3691, 1999.
33) Fleming P, et al : The murine cytomegalovirus homolog, m131/129, is a determinant of viral pathogenicity. J Virol 73 : 6800-6809, 1999.
35) Noda S, et al : Cytomegalovirus MCK-2 controls mobilization and recruitment of myeloid progenitor cells to facilitate dissemination. Blood, 2005. (http://www.bloodjournal.org/cgi/content/abstract/2005051833vl)
36) Mocarski ES, et al : Myeloid cell recruitment and function in pathogenesis and latency. In : Cytomegalovirus : Molecular Biology and Immunology (ed by Reddehase MJ), Caiser Academic Press, Norfolk, 2005.
37) Bukowski JF, et al : Pathogenesis of murine cytomegalovirus infection in natural killer cell-depleted mice. J Virol 52 : 119-128, 1984.
39) Tay CH, Welsh RM : Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. J Virol 71 : 267-275, 1997.
47) Lodoen M, et al : NKG2 D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible gene molecules. J Exp Med 197 : 1245-1253, 2003.
51) Orange JS, Biron CA : Characterization of early IL-12, IFN-αβ, and TNF effects on antiviral state and NK cell response during murine cytomegalovirus infection. J Immunol 156 : 4746-4756, 1996.
52) Dalod M, et al : Dendritic cell responses to early murine cytomegalovirus infection : subset functional specialization and differential regulation by interferon α/β. J Exp Med 197 : 885-898, 2003.
58) Lucin P, et al : Gamma interferon-dependent clearance of cytomegalovirus infection in salivary glands. J Virol 66 : 1977-1984, 1992.
62) MacComlac LP, Grundy JE : Human cytomegalovirus induces an Fcγ receptor (FcγR) in endothelial cells and fibroblasts that is distinct from the human cellular FcγRs. J Infect Dis 174 : 1151-1161, 1996.
63) Thale R, et al : Identification and expression of a murine cytomegalovirus early gene coding for an Fc receptor. J Virol 68 : 7757-7765, 1994.
71) Polic B, et al : Hierarchical and redundunt lymphocyte subset control precludes cytomegalovirus replication during latent infection. J Exp Med 188 : 1047-1054, 1998.
74) Tanaka K, et al : Role of the indigenous bacterial fiora in maintaining virus-specific CD8 T cells in the lungs of mice infected with murine cytomegalovirus (MCMV). (in preparation)
P.420 掲載の参考文献
1) Yasukawa M, et al : Specificity analysis of human CD4+ T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J Virol 67 : 6259-6264, 1993.
2) Flamand I, et al : Immunosuppressive effect of human herpesvirus 60n T-cell functions : suppression of interleukin-2 synthesis and cell proliferation. Blood 85 : 1263-1271, 1995.
3) Furukawa M, et al : Distinct effects of human herpesvirus 6 (HHV-6) and HHV-70n surface molecule expression and function of CD4+ T cells. J Immunol 152 : 5768-5775, 1994.
6) Flamand I, et al : Human herpesvirus 6 induces interleukin-1 beta and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J Virol 65 : 5105-5110, 1991.
7) Arena A, et al : Altered cytokine production after human herpes virus type 6 infection. New Microbiol 22 : 293-300, 1999.
9) Isegawa Y, et al : Human herpesvirus 60pen reading frame U12 encodes a functional β-chemokine receptor. J Virol 72 : 6104-6112, 1998.
10) Milne RS, et al : RANTES binding and down-regulation by a novel human herpesvirus-6β chemokine receptor. J Immunol 164 : 2396-2404, 2000.
14) Inoue Y, et al : Induction of T-cell apoptosis by human herpesvirus 6. J Virol 71 : 3751-3759, 1997.
P.425 掲載の参考文献
14) Tomasec P, et al : Downregulation of natural killer cell-activating ligand CD 155 by human cytomegalovirus UL141. Nat Immunol 6 : 181-188, 2005.
15) Amon TI, et al : Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol 6 : 515-523, 2005.
P.433 掲載の参考文献
1) 沼崎啓 : サイトメガロウイルス感染経路とその臨床的意義. 日本臨牀 56 : 179-183, 1998.
3) Feire AL, et al : Cellular integrins function as entry receptors for human cytomegalovirus via a highly conserved disintegrin-like domain. Proc Natl Acad Sci USA 101 : 15470-15475, 2004.
7) Taylor-Wiedeman J, et al : Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 95 : 3937-3942, 1991.
11) Woodgame RW : Gastrointestinal cytomegalovirus disease. Ann Intern Med 119 : 924-935, 1993.
13) Fish KN, et al : Human cytomegalovirus persistently infects aortic endothelial cells. J Virol 72 : 5661-5668, 1998.
14) 米満吉和ほか : ヒト血管病変におけるサイトメガロウイルス感染とその意義. 日本臨牀 56 : 102-108, 1998.
21) Isegawa Y, et al : Human herpesvirus 6 open reading frame U12 encodes a functional B-chemokine receptor. J Virol 72 : 6104-6112, 1998.
22) Zou P, et al : Human herpesvirus 6 open reading frame U83 encodes a functional chemokine. J Virol 73 : 5926-5933, 1999.
24) Clark D : Human herpesvirus type 6 and multiple sclerosis. Herpes 11 : 112A-119A, 2004.
25) Nishimura K : Le purpllra thrombopenique dans la rubeole scarlatiniforme (exanthema subit des jeunes enfants). Med Hyg 35 : 622-624, 1977.
26) Carrigan DR, Knox KK : Bone marrow suppression by human herpesvirus-6 : comparison of the A and B variants of the virus. Blood 86 : 835-836, 1995.
30) 岩崎琢也, 佐藤由子 : Human herpesvirus 6 (HHV6) と血液腫瘍. 血液フロンティア 9 : 1027-1032, 1999.
32) Wyatt LS, Frenkel N : Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J Virol 66 : 3206-3209, 1992.
34) Kusuhara K, et al : Do second attacks of exanthema subitum result from human herpesvirus 6 reactivation or reinfection? Pediatr Infect Dis J 10 : 468-470, 1991.
P.438 掲載の参考文献
2) Tayler-Wiedeman J, et al : Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells. J Gen Virol 72 : 2059-2064, 1991.
7) Soderberg-Naucler C, et al : Reactivation of latent human cytomegalovirus by allogeneic stimulation of blood cells from healthy donors. Cell 91 : 119-126, 1997.
11) Bolovan-Fritts C, et al : Peripheral blood CD14+ cells from healthy subjects carry a circular conformation of latent cytomegalovirus genome. Blood 93 : 394-398, 1999.
15) Weekes MP, et al : The memory cytotoxic T-lymphocyte (CTL) response to human cytomegalovirus infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo. J Virol 73 : 2099 -2108, 1999.
P.444 掲載の参考文献
1) Cassady KA, Whitley RJ : Pathogenesis and pathophysiology of viral infections of the central nervous system. In : Infection of the Central Nervous System (ed by Scheld WM, et al), p 7-22, Lippincott-Raven Publisher, Philadelphia, 1997.
3) Levine SL : Choroid plexus : target for systemic disease and pathway to the brain. Lab Invest 56 : 231-233, 1987.
8) Conboy TJ, et al : Intellectual development in school-aged children with asymptomatic congenital cytomegalovirus infection. Pediatrics 77 : 801-806, 1986.
16) He J, et al : Infection of primary human fetal astrocytes by human herPesvirus 6. J Virol 70 : 1296-1300, 1996.
19) Dewhurst S : Human herpesvirus type 6 and human herpesvirus type 7 infections of the central nervous system. Herpes 11 (Suppl) : 105A-111A, 2004.
P.449 掲載の参考文献
3) Yamiamoto-Tabata T, et al : Human cytomegalovirus interleukin-10 downregulates metalloproteinase activity and impairs endothelial cell migration and placental cytotrophoblast invasiveness in vitro. J Virol 78 : 2831-2840, 2004.
8) Wroblewska Z, et al : Cytomegalovirus isolation from a chimpanzee with acute demyelinating disease after inoculation of multiple sclerosis brain cells. Infect Immun 25 : 1008-1015, 1979.
13) Institute of Medicine : Vaccines for the 21st century : a tool for decisionmaking (www.nap.edu/books/0309056462/html). National Academy of Science, 2001.
15) Pepperl-Klindworth S, et al : Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles. J Clin Virol 25 (Suppl 2) : S75-85, 2002.
P.454 掲載の参考文献
2) 干場勉ほか : 妊婦のサイトメガロウイルス抗体保有率の低下. 日本臨牀 56 : 193-196, 1998.
3) 西村直子ほか : 各種ウイルスに対する膀帯血の抗体保有状況. 小児感染免疫 16 : 167-172, 2004.
4) 水之江知哉ほか : 当科における妊婦サイトメガロウイルス抗体の保有状況について. 日本周産期・新生児医学会雑誌 40 : 497, 2004.
5) 濱中拓郎ほか : 妊娠初期スクリーニングによる妊婦サイトメガロウイルス (CMV) 抗体保有率と先天性CMV感染症に関する検討. 日産婦誌 56 : 522, 2004.
6) 田川正人ほか : 長崎県下における先天性サイトメガロウイルス感染症の疫学 (第1報) 妊婦の抗体保有率と先天感染の頻度. 日本未熟児新生児学会雑誌 15 : 381, 2003.
7) 伊香加納子ほか : 妊婦のヘルペス科ウイルス抗体スクリーニングに関する疫学的検討. 日本産婦人科感染症研究会学術講演会記録集 20 : 75-79, 2003.
8) 山下美和ほか : 先天性サイトメガロウイルス感染症に関する前方視的研究. 日本産婦人科・新生児血液学会誌 12 : 44-48, 2002.
10) 武田直人ほか : 成人におけるサイトメガロウイルス抗体陽性率とサイトメガロウイルス単核球症に関する研究. 感染症誌 75 : 775-779, 2001.
11) 吉川哲史ほか : 突発性発疹症原因ウイルス (human herpesvirus-6 : HHV-6) の血清疫学調査. 日児誌 93 : 1798-1800, 1989.
12) 垣本和宏ほか : 初妊婦におけるHHV-6抗体価とHHV-6感染が妊娠に与える影響の検討. 臨床とウイルス 21 : 44-49, 1993.
13) 大橋正博ほか : 経時的な検体採取による妊婦でのHHV-6, HHV-7感染状況の解析. 臨床と微生物 28 : 431-436, 2001.
14) 西村直子ほか : 各種ウイルスに対する臍帯血の抗体保有状況. 小児感染免疫 16 : 167-172, 2004.
15) 吉川哲史ほか : Human herpesvirus (HHV) -7の血清ウイルス学的検討. 臨床とウイルス 21 : 333-337, 1993.
P.459 掲載の参考文献
1) 矢原健, 中山雅弘 : 妊婦・小児におけるサイトメガロウイルス抗体の疫学的検討. 臨床と微生物 20 : 475-478, 1993.
2) 矢吹朗彦, 干場勉ほか : 妊婦のサイトメガロウイルス感染に関する研究. 石川県立中央病院雑誌 15 : 169 : 29-31, 1994.
3) 越田理恵, 橋本浩之ほか : 先天性サイトメガロウイルス感染症-多彩な臨床像の比較検討および妊婦の抗体保有率とウイルスゲノム検出の試み-. 新生児誌 33 : 228-233, 1997.
4) 干場勉 : CMV感染の疫学. JHIF Workshop Proceedings, p 78-79, 2001.
6) Stagno S : Cytomegalovirus. In : Infectious Disease of the Fetus and Newborn Infant (ed by Remington JR, Klein JO), p 389-424, WB Saunders, Philadelphia, 2001.
8) 金子政時 : 先天性CMV感染症-臨床所見によるハイリスク群抽出の検討-. JHIF Workshop Proceedings, p 80-81, 2001.
9) Kimberlin DW, et al : Ganciclovir (GCV) treatment of symptomatic congenital cytomegalovirus (CMV) infections ; results of a phase 3 randomized trial. In : Program and Abstracts of the Fortieth Interscience Conference on Antimicrobial Agents and Chemotherapy, Toront, Canada, 2000, abstract 1942, p 274, American Society for Microbiology, Washington, DC, 2000.
P.465 掲載の参考文献
1) Mocarski E-S, Courcelle C-T : Cytomegaloviruses and their replication. In : Fields Virology, 4th ed, Vol 2 (ed by Knipe DM, et al), p 2629-2673, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) 峰松俊夫, 南嶋洋一 : サイトメガロウイルス : 白血球中サイトメガロウイルスpp65抗原検出. 綜合臨牀 52 (1) : 153-158, 2003.
3) The T-H, et al : Cytomegalovirus antigenemia. Rev Infect Dis 12 (Suppl 7) : S734-744, 1990.
7) 牛久保宏 : LAMP法の原理-遺伝子の簡易・迅速な増幅法-. ウイルス 54 : 107-112, 2004.
8) Gerna G, et al : Clinical significance of expression of human cytomegalovirus pp67 late transcript in heart, lung, and bone marrow transplant recipients as determined by nucleic acid sequence-based amplification. J Clin Microbiol 37 : 902-911, 1999.
9) Gerna G, et al : Human cytomegalovirus immediate-early mRNA detection by nucleic acid sequence-based amplification as a new parameter for preemptive therapy in bone marrow transplant recipients. J Clin Microbiol 38 : 1845-1853, 2000.
10) Erice A : Resistance of human cytomegalovirus to antiviral drugs. Clin Microbiol Rev 12 : 286-297, 1999.
P.470 掲載の参考文献
10) Yoshikawa T, et al : Distribution of antibodies to a causative agent of exanthem subitum (human herpesvirus-6) in healthy individuals. Pediatrics 84 : 675-677, 1989.
18) Salahuddil SZ, et al : Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science 234 : 596-601, 1986.
P.475 掲載の参考文献
6) 国立感染症研究所感染症情報センターホームページ (http://idsc.nih.go.jp/index-j.html).
10) Dibata M, et al : Inheritance of chromosomally integrated human herpesvirus 6 DNA. Blood 94 : 1545-1549, 1999.
11) Tanaka-Taya K, et al : Human herpesvirus 6 (HHV-6) is transmitted from parent to child in an integrated form and characterization of cases with chromosomally integrated HHV-6 DNA. J Med Virol 73 : 465-473, 2004.
12) Nagayama T, et al : Early diagnosis of exanthem subitum and isolation of its causative virus. Med J Kagoshima Univ 8 : 212-220, 1956.
P.479 掲載の参考文献
8) 橋本公二 : Stevens-Johnson症候群, toxic epidermal necrolysis (TEN) とhypersensitivity syndromeの診断基準および治療指針の研究. 厚生科学特別研究事業, 平成13年度総括研究報告, 2002.
P.483 掲載の参考文献
1) 森毅彦, 池田康夫 : 同種造血幹細胞移植の現状と限界. 移植と人工臓器 (浅野茂隆ほか編), p49-57, 岩波書店, 2001.
2) 森毅彦, 岡本真一郎 : 造血幹細胞移植時の感染対策. 血液フロンティア 13 : 69-77, 2003.
3) 高橋雅彦 : 輸血感染症の展望. 血栓止血誌 15 : 483-500, 2004.
5) 安藤潔, 森毅彦 : サイトメガロウイルス感染と造血障害. 日内会誌 87 : 360-364, 1998.
6) Myers JD, et al : Risk factors for cytomegalovirus infection after human marrow transplantation. J Infect Dis 153 : 478-488, 1986.
9) Holmberg LA, et al : lncreased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation. Blood 94 : 4029-4035, 1999.
11) Boeckh M, et al : Successful monitoring of a pp65 antigenemia-based early treatment strategy for prevention of cytomegalovirus disease in allogeneic marrow transplant recipient. Blood 93 : 1781-1782, 1999.
12) Gondo H, et al : Cytomegalovirus (CMV) antigenemia for rapid diagnosis and monitoring of CMV-asssociated disease after bone marrow transplantation. Br J Haematol 86 : 130-137, 1994.
18) Schmidt GM, et al : Ganciclovir/immunoglobulin combination therapy for the treatment of human cyte megalovirus-associated interstitial pneumonia in bone marrow allograft recipients. Transplantation 46 : 905-907, 1988.
20) Prentice HG, et al : Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation. European Acyclovir for CMV Prophylaxis Study Group. Lancet 343 : 749-753, 1994.
22) Messori A, et al : Efficacy of hyperimmune anti-cytomegalovirus immunoglobulins for the prevention of cytomegalovirus infection in recipients of allogeneic bone marrow transplantation : a meta-analysis. Bone Marrow Transplant 13 : 163-167, 1994.
23) Li CR, et al : Recovery of HLA-restricted cytomegalovirus (CMV) -specific T-cell responses after allogeneic bone marrow transplant : correlation with CMV disease and effect of ganciclovir prophylaxis. Blood 83 : 1971-1979, 1994.
24) Boeckh M, et al : Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation : A randomized double-blind study. Blood 88 : 4063-4071, 1996.
P.488 掲載の参考文献
2) Yoshikawa T, et al : Human herpesvirus-6 infection in bone marrow transplantation. Blood 78 : 1381-1384, 1991.
5) 井平勝 : 小児生体肝移植後のhuman herpesvirus 6感染に関する前方視的研究. 臨床と微生物 25 : 69-72, 1998.
8) Cone RW, et al : Human herpesvirus 6 in lung tissue from patients with pneumonitis after bone marrow transplantation. N Engl J Med 329 : 311-318, 1993.
P.494 掲載の参考文献
2) Snell CR, et al : Physical performance and prediction of 2-5A synthetase/RNase L antiviral pathway activity in patients with chronic fatigue syndrome. In Vivo 16 (2) : 107-109, 2002.
6) Soto NE, Straus SE : Chronic Fatigue Syndrome and Herpesviruses : the Fading Evidence. Herpes 7 (2) : 46-50, 2000.
7) 近藤一博 : ヘルペスウイルス感染と慢性疲労. 医学のあゆみ 204 (5) : 398-402, 2003.
8) 近藤一博 : ヘルペスウイルスと疲労. ウイルス 55 (1) : 9-18, 2005.
P.499 掲載の参考文献
1) Numazaki K : Immunological evaluation of children with congenital cytomegalovirus infection and infected women during pregnancy. Current Trends in Immunology 5 : 45-54, 2003.
14) Whitley RJ, et al : Ganciclovir treatment of symptomatic congenital cytomegalovirus infection : results of a phase II study. J Infect Dis 175 : 1080-1086, 1997.
15) Stagno S, Cloud GA : Working parents : the impact of day care and breast-feeding on cytomegalovirus infections in offspring. Proc Natl Acad Sci USA 91 : 2384-2389, 1997.
P.503 掲載の参考文献
1) Litter E, et al : Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analogue ganciclovir. Nature 358 : 160-162, 1992.
3) Cihlar T, Chen MS : Identhication of enzymes catalyzing two-step phosphorylation of cidofovir and the effect of cytomegalovirus infection on their activities in the host cells. Mol Pharmacol 50 : 1502-1510, 1996.
5) Cainem F, Vento S : Infection and solid organ transplant rejection : a cause-and-effect relationship? Lancet Infect Dis 2 : 539-549, 2002.
6) Salmon-Ceron D : Cytomegalovirus infection : the point in 2001. HIV Med 2 : 255-259, 2001.
7) Parren BA, et al : Cytomegalovirus retinitis and optic neuritis in a child with severe combined immunodeficiency syndrome. Retina 16 : 117-121, 1996.
11) Tanaka-Kitajima N, et al : Ganciclovir therapy for congenital cytomegalovirus infection in six infants. Pediatr Infect Dis J 24 : 786-792, 2005.
P.507 掲載の参考文献
P.511 掲載の参考文献
10) Lurain NS, et al : Point mutations in the DNA polymerase gene of human cytomegalovirus that result in resistance to antiviral agents. J Virol 66 : 7146-7152, 1992.
13) Lurain NS, et al : Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir. J Virol 68 : 4427-4431, 1994.
14) Baldanti F, et al : Single amino acid changes in the DNA polymerase confer foscarnet resistance and slow-growth phenotype, while mutations in the UL97-encoded phosphotransferase confer ganciclovir resistance in three double-resistant human cytomegalovirus strains recovered from patients with AIDS. J Virol 70 : 1390-1395, 1996.
15) Jabs DA, et al : Incidence of foscarnet resistance and cidofovir resistance in patients treated for cytomegalovirus retinitis. The Cytomegalovirus Retinitis and Viral Resistance Study Group. Antimicrob Agents Chemother 42 : 2240-2244, 1998.
P.517 掲載の参考文献
1) 井原征治ほか : 大腸菌発現系でのヒト抗サイトメガロウイルス中和抗体の作製. 日本臨牀 56 : 161-166, 1998.
3) 長塚靖子ほか : EBウイルス-形質転換法を用いたヒト抗体産生細胞ライブラリー. BIO Clinica 13 : 77-82, 1998.
4) Takekoshi M, et al : Cloning and expression of human anti-tumor necrosis factor-α monoclonal antibodies from Epstein-Barr Virus transformed oligoclonal libraries. J Biochem 130 : 299-303, 2001.
7) Ohlin M, et al : Fine specificity of the human immune response to the major neutralization epitopes expressed on cytomegalovirus gp58/116 (gB), as determined with human monoclonal antibodies. J Virol 67 : 703-710, 1993.
P.522 掲載の参考文献
5) 近藤一博 : ヘルペスウイルス感染と慢性疲労. 医学のあゆみ 204 (5) : 398 -402, 2003.
9) Inoue N, et al : Alphaherpesvirus origin-binding protein homolog encoded by human herpesvirus 6B, a betaherpesvirus, binds to nucleotide sequences that are similar to ori regions of alphaherpesviruses. J Virol 68 (7) : 4126-4136, 1994.
11) Romi H, et al : Tamplicon-7, a novel T-lymphotropic vector derived from human herPesvirus 7. J Virol 73 (8) : 7001-7007, 1999.

IV γヘルペスウイルス - EBウイルス ( EBV ) とカポジ肉腫関連ヘルペスウイルス ( KSHV ) -

P.530 掲載の参考文献
1) Kieff E, Rickinson AB : Epstein-Barr virus and its replication. In : Fields Virology, 4th ed (ed by Firlds BN, et al), p 2511-2573, Lippincott-Raven, Philadelphia, New York, 2002.
2) Moore PS, Chang Y : Kaposi's Sarcoma-Associated Herpesvirus. In : Fields Virology, 4th ed (ed by Firlds BN, et al), p 2803-2833, Lippincott-Raven, Philadelphia, New York, 2002.
3) Moore PS, Chang Y : Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356 : 499-516, 2001.
4) Damania B : Oncogenic γ-herpesviruses : comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2 : 656-668, 2004.
6) McGeoch D : Molecular evolution of the γ-Herpesvirinae. Philos Trans R Soc Lond B Biol Sci 356 : 421-435, 2001.
P.536 掲載の参考文献
1) Rickinson AB, Kieff E : Epstein-Barr virus. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2575-2627, Lippincott Williams and Wilkins, Philadelphia, 2001.
2) Kieff E, Rickinson AB : Epstein-Barr virus and its replication. In : Fields Virology, 4th ed (ed by Knipe DM, Howley PM), p 2511-2574, Lippincott Williams and Wilkins, Philadelphia, 2001.
3) 草野秀一 : ウイルスの構造と遺伝子 (5) BARTs, BARF1. EBウイルス (高田賢蔵ほか編), p 47-58, 診断と治療社, 2003.
9) Jason S, et al : A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells. J Virol 78 : 12857-12867, 2004.
P.542 掲載の参考文献
7) Chatteriee M, et al : Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298 : 1432-1435, 2002.
8) Barnes B, et al : G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391 : 86-89, 1998.
9) Li M, et al : Kaposi's sarcoma-associated herpesvirus viral interferon regtilatory factor. J Virol 72 : 5433-5440, 1998.
10) Zimring JC, et al : Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1 mediated transcription. J Virol 72 : 701-707, 1998.
P.546 掲載の参考文献
6) Fukuda M, et al : A mechanism in Epstein-Barr virus oncogenesis : Inhibition of transforming growth factor-β1-mediated induction of MAPK/p21 by LMP1. Virology 302 : 310-320, 2002.
9) Fukuda M, et al : Effect of transforming grown factor-β1 on the cell growth and Epstein-Barr virus (EBV) reactivation in EBV-infected epithelial cell lines. Virology 288 : 109-118, 2001.
P.550 掲載の参考文献
1) Moore PS, Chang Y : Kaposi's sarcoma-associated herpesvirus. In : Fields Virology, 4th ed (ed by Knipe DM, et al), p 2803-2833, Lippincott Williams & Wilkins, Philadelphia, 2001.
8) Akula SM, et al : Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) infection of human fibroblast cells occurs through endocytosis. J Virol 77 : 7978-7990, 2003.
10) Lukac DM, et al : Transcriptional activation by the product of open reading frame 50 of Kaposi's sarcoma-associated herpesvirus is required for lytic viral reactivation in B cells. J Virol 73 : 9348-9361, 1999.
P.557 掲載の参考文献
P.562 掲載の参考文献
P.567 掲載の参考文献
4) Tamaru Y, et al : Absence of bcl-2 expression by activated CD45RO+ lymphocytes in acute infectious mononucleosis supporting their susceptibility to programmed cell death. Blood 82 : 521-527, 1993.
P.575 掲載の参考文献
P.579 掲載の参考文献
1) Rickinson AB, Kieff E : Epstein-Barr virus. In : Field's Virology, 4th ed (ed by Knipe DM, et al), p2575-2627, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Marchini A, et al : BHRF1, the Epstein-Barr virus gene with homology to Bcl-2, is dispensable for B-lymphocyte transformation and Virus replication. J Virol 65 : 5991-6000, 1992.
3) Kieff E, Rickinson AB : Epstein-Barr virus and its replication. In : Field's virology, 4th ed (ed by Knipe DM, et al), p 2511-2573, Lippincott Williams & Wilkins, Philadelphia, 2001.
10) Nanbo A, et al : Epstein-Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt's lymphoma. EMBO J 21 : 954 -965, 2002.
P.583 掲載の参考文献
1) Rickinson AB, Kieff E : Epstein-Barr virus. In : Fields Virology (ed by Knipe DM, et al), p 2575-2627, Lippincott Williams & Wilkins, Philadelphia, 2001.
2) Moore PS, Chang Y : Kaposi's sarcoma-associated herpesvirus. In : Fields Virology (ed by Knipe DM, et al), p 2803-2833, Lippincott Williams & Wilkins, Philadelphia, 2001.
6) Damania B : Oncogenic γ-herpesviruses : comparison of viral proteins involved in tumorigenesis. Nat Rev Microbiol 2 : 656-668, 2004.
7) Kieff E, Rickinson AB : Epstein-Barr virus and its replication. In : Fields Virology (ed by Knipe DM, et al), p 2511-2573, Lippincott Williams & Wilkins, Philadelphia, 2001.
14) Nash AA, et al : Natural history of murine γ-herpesvirus infection. Philos Trans R Soc Lond B Biol Sci 356 : 569-579, 2001.
15) Speck SH, Virgin HW : Host and viral genetics of chronic infection : amouse model of gamma-herpesvirus pathogenesis. Curr Opin Microbiol 2 : 403-409, 1999.
P.588 掲載の参考文献
1) Lopes V, et al : Epstein-Barr virus-associated cancers : aetiology and treatment. Herpes 10 : 78-82, 2003.
4) Tao Q, et al : The Epstein-Barr Virus major latent promoter QP is constitutivly active, hypomethylated, and methylation sensitive. J Virol 72 : 7075-7083, 1998.
P.592 掲載の参考文献
8) Lan K, et al : Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding Protein Jκ, the major downstream effector of the Notch signaling pathway. J Virol 79 : 3468-3478, 2005.
12) Liang Y, et al : The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jκ (CSL), the target of the Notch signaling pathway. Genes Dev 16 : 1977-1989, 2002.
P.597 掲載の参考文献
1) 佐藤賢文, 松岡雅雄 : AIDS関連リンパ腫. 診断と治療 90 : 1300-1304, 2002.
4) Breen EC, et al : Infection with HIV is associated with elevated IL-6 levels and production. J Immunol 144 : 480-484, 1990.
6) Camilleri-Broet S, et al : AIDS-related primary brain lymphomas : histopathologic and immunohistochemical study of 51 cases. The French Study Group for HIV-Associated Tumors. Hum Pathol 28 : 367-374, 1997.
8) Muller S, Kohler H : B cell superantigens in HIV-1 infection. Int Rev Immunol 14 : 339-349, 1997.
9) Rabkin CS, et al : Chemokine and chemokine receptor gene variants and risk of non-Hodgkin's lymphoma in human immunodeficiency virus-1-infected individuals. Blood 93 : 1838-1842, 1999.
10) Dean M, et al : Reduced risk of AIDS lymphoma in individuals heterozygous for the CCR5-delta32 mutation. Cancer Res 59 : 3561-3564, 1999.
12) Monini P, et al : Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93 : 4044-4058, 1999.
P.602 掲載の参考文献
1) Rickinson AB, Kieff E : Epstein-Barr virus. In : Virology, 4th ed (ed by Fields BN, et al), p 2575-2627, Lippincott-Raven, Philadelphia, 2001.
2) 高田賢藏 (監), 柳井秀雄, 清水則夫 (編) : EBウイルス, 診断と治療社, 2003.
8) Scholle F, et al : Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74 : 10681-10689, 2000.
16) Nanbo A, et al : Epstein-Barr virus RNA confers resistance to interferon-α-induced apoptosis in Burkitt's lymphoma. EMBO J 5 : 954 -965, 2002.
17) Iwakiri D, et al : Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA. Cancer Res 63 : 7062-7067, 2003.
P.607 掲載の参考文献
3) Seo T, et al : Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor l inhibits transforming growth factor-β signaling. Cancer Res 65 : 1738-1747, 2005.
4) Fujimuro M, et al : a novel viral mechanism for dysregulation of β-catenin in Kaposi's sarcoma-associated herpesvirus latency. Nat Med 9 : 300-306, 2003.
6) Tomita M, et al : The Kaposi's sarcoma-associated herpesvirus K-bZIP protein represses transforming growth factor β signaling through interaction with CREB-binding protein. Oncogene 23 : 8272-8281, 2004.
8) Dadke D, et al : Activation of p21-activated kinase 1-nuclear factor rc B signaling by Kaposi's sarcoma-associated herpes virus G protein-coupled receptor during cellular transformation. Cancer Res 63 : 8837-8847, 2003.
12) McComick C, Ganem D : The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs. Science 307 : 739-741, 2005.
P.612 掲載の参考文献
1) 今井章介 : 健康人におけるEBウイルス不顕性感染のウイルス学的・免疫学的研究 : 伝染性単核症患者との比較検討. 北海道医学雑誌 65 : 481-492, 1990.
2) 日沼頼夫ほか : 我が国におけるEBウイルスの伝播状況. 日本医事新報 2312 : 27, 1968.
3) 相川勝悟ほか : EBVの侵浸状況 (山形県, 1979年). 山形衛研報 17 : 15-20, 1984.
6) 金兼弘和, 宮脇利男 : 伴性リンパ増殖性疾患 (Duncan症候群). 血液・腫瘍科 48 : 357-365, 2004.
7) 今宿晋作 : 血球貪食症候群. 小児内科 35 : 1220-1224, 2003.
8) 生嶋聡ほか : 小児科領域におけるhemophagocytic syndrome. 日本小児血液学会雑誌 52 : 22-27, 1992.
9) 脇口宏 : 慢性活動性EBウイルス感染症はEBウイルス関連リンパ腫/白血病か? 日児誌 107 : 2-9, 2003.
12) 黒田正幸, 今井章介 : 伝染性単核球症およびウイルス関連腫瘍性増殖疾患. 日本臨牀 61 (増刊号 2) : 222-228, 2003.
13) 小林信一 : EBウイルス感染症と合併症. 小児内科 37 : 88-92, 2005.
14) 岡部正文 : Hodgkinリンパ腫. 日本臨牀 59 (増刊号7) : 557-565, 2001.
16) 島田忠人ら : EBVによる癌化の分子機構. 日本臨牀 59 (増刊号4) : 60-64, 2001.
P.616 掲載の参考文献
6) Eagles EA, et al : Identifying human herpesvirus 8 infection : performance characteristics of serologic assays. J Acquir Immune Defic Syndr 23 : 346-354, 2000.
13) Angeloni A, et al : High prevalence of antibodies to human herpesvirus 8 in relatives of patients with classic Kaposi's sarcoma from Sardinia. J Infect Dis 177 : 1715, 1998.
P.620 掲載の参考文献
4) Rowe M, et al : Three pathways of Epstein-Barr virus gene activation from EBNA1-positive latency in B lymphocytes. J Virol 66 : 122-131, 1992.
P.624 掲載の参考文献
1) Fujii T, et al : Seroprevalence of HHV-8 in HIV-1 positive and negative populations in Japan. J Med Virol 57 : 159-162, 1999.
10) Lallemand F, et al : Quantitative analysis of human herpesvirus 8 viral load using a real-time PCR assay. J Clin Microbiol 38 : 1404-1408, 2000.
11) White IE, Campbell TB : Quantitation of cell-free and cell-associated Kaposi's sarcoma-associated herpesvirus DNA by real-time PCR. J Clin Microbiol 38 : 1992-1995, 2000.
P.629 掲載の参考文献
2) 脇口宏ほか : 乳幼児の急性Epstein-Barr (EB) ウイルス感染症の免疫学的研究. EBウイルス抗体の年齢, 病型による比較. 臨床とウイルス 15 : 247・-253, 1987.
3) Miyashita E, et al : Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 71 : 4882-4891, 1997.
5) Sumaya CV, Ench Y : Epstein-Barr virus infectious mononucleosis in children. 1. Clinical and general laboratory findings. Pediatrics 75 : 1003, 1985.
6) Sumaya CV, Ench Y : Epstein-Barr Virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 75 : 1011, 1985.
7) 脇口宏ほか : 伝染性単核球症におけるリンパ球サブセットの分析. 日児誌 95 : 2228-2232, 1991.
P.634 掲載の参考文献
5) Kimura H, et al : Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 37 : 132-136, 1999.
10) 脇口宏ほか : 慢性活動性Epstein-Barr (EB) ウイルス感染症児の免疫学的研究 (1) 特異的キラーT細胞とNK細胞活性低下について. 日児誌 90 : 1572, 1986.
P.638 掲載の参考文献
1) Weiss LM, et al : Localization of Epstein-Barr viral DNA to Reed-Sternberg cells in Hodgkin's disease. N Engl J Med 320 : 502-506, 1989.
2) Jaffe ES, et al : World Health Organization Classhification of Tumours Series. Pathology & Genetics. Tumours of Hematopoietic and Lymphoid Tissues, IARC Press, Lyon, 2001.
5) Shimoyama Y, et al : Senile Epstein -Barr Virus-associated B-cell lymphoproliferative disorders : a mini review. J Clin Exp Hematopathol, 2005. (in press)
8) Asano N, et al : Nodal peripheral T-cell lymphoma of unspechied type : a reappraisal with special reference to the prognostic significance of the expression of cytotoxic molecules. Am J Surg Pathol 29 : 1284-1293, 2005.
9) 河敬世, 石原重彦 : 慢性活動性EBウイルス感染症. 病理と臨床 13 : 1091-1097, 1995.
10) Imashuku S : Advances in the management of hemophagocytic lymphohistiocytosis. Int J Hematol 72 : 1-11, 2000.
11) 戸倉新樹 : 皮膚の悪性リンパ腫-皮膚のNK細胞リンパ腫. 血液・腫瘍科 40 : 401-408, 2000.
12) 岩月啓氏 : 悪性リンパ腫の主な疾患単位に関する病理学的・臨床的諸問題一種痘様水疱症と皮膚EBウイルス関連リンパ腫. 血液・腫瘍科 42 : 349-356, 2001.
P.646 掲載の参考文献
3) Paya CV, et al : Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation 68 (10) : 1517-1525, 1999.
8) Tai D, et al : Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder : analysis of prognostic variables and long-term follow-up of 42 adult patients. Transplantation 71 : 1076-1088, 2001.
11) Kato H, et al : Diagnosis of Epstein-Barr virus 1ymphoma after liver transplantation. Gann Monogr Cancer Res 45 : 149-153, 1998.
12) Egawa H, et al : Application of in situ hybridization technique for quantitative assessment of ongoing symptomatic Epstein-Barr virus infection after living related liver transplantation. Clin Transplant 12 : 116-122, 1998.
P.650 掲載の参考文献
1) Raab-Traub N : Epstein-Barr virus in the pathogenesis of NPC. Semin Cancer Biol 12 : 431-441,
3) 吉崎智一ほか : EBウイルスと上咽頭癌. 臨床と微生物 26 : 503-505, 1999.
4) Tam JS : Epstein-Barr virus serological markers. In : Nasopharyngeal Carcinoma (ed by van Hasselt CA, et al), p 165-168, The Chinese University Press, Hong Kong, 1999.
6) 吉崎智一ら : EBウイルスと発癌. 化学療法の領域 16 : 1690 -1696, 2000.
11) Okan I, et al : The EBV-encoded LMPI protein inhibits p53-triggered apoptosis but not growth arrest. Oncogene 11 : 1027-1031, 1995.
12) Yoshizaki T, et al : Epstein-Barr Virus, invasion and metastasis. In : Epstein-Barr Virus (ed by Robertson ES), p 171-196, Caister Academic Press, Linton, 2005.
13) Khanna R, et al : Peptide transporter (TAP-1 and TAP-2) -independent endogenous processing of Epstein-Barr virus (EBV) latent membrane protein 2A : implications for cytotoxic T-lymphocyte control of EBV-associated malignancies. J Virol 70 : 5357-5362, 1996.
14) Scholle F, et al : Epstein-Barr virus LMP2A transforms epithelial cells, inhibits cell differentiation, and activates Akt. J Virol 74 : 10681-10689, 2000.
P.655 掲載の参考文献
1) Shibata D, et al : Association of Epstein-Barr virus with undifferentiated gastric carcinomas with intense lymphoid infiltration. Lymphoepithelioma-like carcinoma. Am J Pathol 139 : 469-474, 1991.
2) Shibata D, Weiss LM : Epstein-Barr virus-associated gastric adenocarcinoma. Am J Pathol 140 : 769-774, 1992.
3) Tokunaga M, et al : Epstein-Barr virus in gastric carcinoma. Am J Pathol 143 : 1250-1254, 1993.
6) Levine LI, Levine PH : The epidemiology of Epstein-Barr virus-associated human cancers. Gann Monogr Cancer Res 45 : 51-74, 1998.
10) Fukayama M, et al : Epstein-Barr virus-associated gastric carcinoma and Epstein-Barr virus infection of the stomach. Lab Invest 71 : 73-81, 1994.
11) Hayashi K, et al : In situ detection of Epstein-Barr virus in the gastric glands with intestinal meta-plasia. Am J Gastroenterol 91 : 1481, 1996.
18) Imai S, et al : Cell-to-cell contact as an efficient mode of Epstein-Barr virus infection of diverse human epithelial cells. J Virol 72 : 4371-4378, 1998.
19) Nishikawa J, et al : Epstehl-Barr virus promotes epithelial cell growth in the absence of EBNA2 and LMP1 expression. J Virol 73 : 1286-1292, 1999.
20) Iwasaki Y, et al : Establishment and characterization of a human Epstein-Barr vinls-associated gastric carcinoma in SCID mice. J Virol 72 : 8321-8326, 1998.
23) Nishikawa J, et al : Upregulation of the truncated basic hair keratin 1 (hHb1-ΔN) in carcinoma cells by Epstein-Barr virus (EBV). Int J Cancer 107 : 597-602, 2003.
24) Iwakiri D, et al : Autocrine growth of Epstein-Barr virus-positive gastric carcinoma cells mediated by an Epstein-Barr virus-encoded small RNA1. Cancer Res 63 : 7062-7067, 2003.
26) zur Hausen A, et al : Unique transcription pattern of Epstein-Barr virus (EBV) in EBV-carrying gastric adenocarcinomas : expression of the transforming BARF1 gene. Cancer Res 60 : 2745-2748, 2000.
30) Sakuma K, et al : High-density methylation of p14ARF and p16 IKK4α in a in Epstein-Barr virus-associated gastric carcinoma. Int J Cancer 112 : 273-278, 2004.
31) Chong J-M, et al : Interleukin-1β expression in human gastric carcinoma with Epstein-Barr virus infection. J Virol 76 : 6825-6831, 2002.
P.661 掲載の参考文献
2) Yamamoto T, et al : Comparative cytological studies on Epstein-Barr virus-infected natural killer (NK) lymphocytes from the blood and established cell lines of a patient with hypersensitivity to mosquito bites. J Am Acad Dermatol. (in press)
5) Iwatsuki K, et al : A pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematological disorders. Arch Dermatol. (in press)
6) Morizane S, et al : A pivotal role of cytotoxic T lymphocytes in the formation of umbilicated viral vesicles. Br J Dermatol. (in press)
P.667 掲載の参考文献
4) Henter J-I, et al : HLH-94 : a treatment protocol for hemophagocytic lymphohistiocytosis. HLH Study Group of the Histiocyte Society. Med Pediatr Oncol 28 : 342-347, 1997.
8) Takahashi N, et al : Lymphoma-associated hemophagocytic syndrome in Japan. Rinsho Ketsueki 40 : 542-549, 1999.
9) 今宿晋作ほか : EBウイルス関連血球貪食性リンパ組織球増殖症 (EBV-HLH). 炎症と免疫 11 : 302-308, 2003.
14) 金兼弘和, 宮脇利雄 : EBウイルスはX連鎖リンパ増殖症候群 (XLP) 発症に関わっているか. 血液フロンティア 15 : 85-92, 2005.
15) Imashuku S, et al : Longitudinal follow-up of patients with Epstein-Barr virus (EBV) -associated haemophagocytic lymphohistiocytosis (HLH). Haematologica 89 : 183-188, 2004.
P.671 掲載の参考文献
3) Moore PS, Chang Y : Kaposi's sarcoma-Associated Herpesvirus, Lippincott Williams & Wilkins, Philadelphia, 2001.
4) Buchbinder A, et al : Clinical manifestations and histopathologic features of classic, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. In : Color Atlas of AIDS, WB Saunders, Philadelphia, 1996.
14) Aoki Y, et al : Angiogenesis and hematopoiesis induced by Kaposi's sarcoma-associated herpesvirus-encoded interleukin-6. Blood 93 : 4034-4043, 1999.
P.676 掲載の参考文献
1) 栄鶴義人 : 新規抗ヘルペスウイルス剤. 特集2 抗ウイルス薬の現状と将来. ウイルス 55 : 95-104, 2005.
4) Oertek SH, Riess H : Antiviral treatment of Epstein-Barr virus associated lymphoproliferations. Recent Results Cancer Res 159 : 89-95, 2002.
7) Feng WH, et al : Chemotherapy induces lytic EBV replication and confers ganciclovir susceptibility to EBV-positive epithelial cell tumors. Cancer Res 62 : 1920-1926, 2002.
10) Zacny VL, et al : Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside : novel antiviral mechanism of 5, 6-dichloro-2- (isopropylamino) -1-beta-L-ribofuranosyl-1H-benzimidazole. J Virol 73 : 7271-7277, 1999.
12) Liebemlan J, et al : Interfering With disease : opportunity and roadblocks to harnessing RNA interference. Trends Mol Med 9 : 397-403, 2003.
P.680 掲載の参考文献
4) Haque T, et al : DH Reconstitution of EBV-specific T cell immunity in solid organ transplant recipients. J Immunol 160 : 6204-6209, 1998.
8) Lin CL, et al : Immunization with Epstein-Barr Virus (EBV) peptide-pulsed dendritic cells induces functional CD8+ T-cell immunity and may lead to tumor regression in patients with EBV-positive nasopharyngeal carcinoma. Cancer Res 62 : 6952-6958, 2002.
9) Voo KS, et al : Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes. J Exp Med 199 : 459-470, 2004.
P.686 掲載の参考文献
1) Kawa K : Epstein-Barr virus-associated diseases in humans. Int J Hematol 71 : 108-117, 2000.
2) 高田賢蔵 : EBウイルスの構造と機能からみたウイルス潜伏感染と発ガンの機序. 血液フロンティア 15 : 13-20, 2005.
3) 河敬世 : いわゆる慢性活動性EBウイルス感染症の診断と治療. ウイルス 52 : 257-260, 2002.
5) 河敬世 : Epstein-Barr (EB) ウイルス感染症の診断と治療. 最新医学 60 : 171-178, 2005.
7) 河敬世ほか : 血球貪食症候群の診断と治療. 臨床血液 46 : 418-423, 2005.
8) 河敬世ほか : 慢性活動性EBウイルス感染症の治療法. 血液フロンティア 15 : 39-48, 2005.
10) 尾山卓, 中村栄男 : 加齢性EBV関連B細胞リンパ増殖異常症. 血液・腫瘍 48 : 405-409, 2004.
12) 穴戸清一郎 : EBウイルス関連PTLDの臨床像. 今日の移植 16 : 356-361, 2003.
14) 坂田尚己ほか : Reduced intensity stem cell transplantationを施行した慢性活動性EBウイルス感染症. 臨床血液 45 : 393-396, 2004.
15) 河敬世 : 造血細胞移植の新しい潮流. 日児誌 108 : 1325-1332, 2004.
P.690 掲載の参考文献
1) Gill PS, et al : Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin, and vincristine in AIDS-related KS. J Clin Oncol 14 : 2253, 1996.
P.695 掲載の参考文献
1) 高田賢蔵 (監), 柳井秀雄, 清水則夫 (編) : EBウイルス, 診断と治療社, 2003.
3) Wade-Martins R, et al : An infectious transfer and expression system for genomic DNA loci in human and mouse cells. Nat Biotechnol 19 : 1067-1070, 2001.
7) Moosmann A, et al : Bcells immortalized by a mini-Epstein-Barr virus encoding a foreign antigen efficiently reactivate specific cytotoxic T cells. Blood 100 : 1755-1764, 2002.
9) Shimizu N, et al : Clonal propagation of Epstein-Barr virus (EBV) recombinants in EBV-negative Akata cells. J Virol 70 : 7260-7263, 1996.

最近チェックした商品履歴

Loading...